Professional Documents
Culture Documents
REVIEW
ASSESS
COMMUNICATE
TRACER
QUESTIONS
EDUCATE
REPORT
INCLUDES DOWNLOADABLE
TOOLS AND ADDITIONAL MATERIALS!
Content Development Manager: Lisa K. Abel
Senior Project Manager: Allison Reese
Associate Director, Publications: Helen M. Fry, MA
Associate Director, Production and Meeting Support: Johanna Harris
Executive Director: Catherine Chopp Hinckley, MA, PhD
Joint Commission/ JCR Reviewers: Lynne Bergero, Lynn Berry, Branetta Bronson-Ross, Maureen Carr, Caroline
Christensen, Kathy Clark, Tina Cordero, Trina Crow, Susan Cymbor, Lisa DiBlasi Moorehead, Julia Finken, Mary Pat Hall,
Jim Kendig, Michael Kulczycki, Peggy Lavin, Heather Martin, Megan Marx-Varela, John Maurer, Ken Monroe, Kelly
Podgorny, Ron Quicho, Donna Rockwell, Laura Smith, Katherine Tolomeo, Tabitha Vieweg, Lisa Waldowski, Joyce Webb,
James Woodson, Paul Ziaya
Joint Commission Resources educational programs and publications support, but are separate from, the accreditation
activities of The Joint Commission. Attendees at Joint Commission Resources educational programs and purchasers of
Joint Commission Resources publications receive no special consideration or treatment in, or confidential information
about, the accreditation process.
The inclusion of an organization name, product, or service in a Joint Commission Resources publication should not be
construed as an endorsement of such organization, product, or service, nor is failure to include an organization name,
product, or service to be construed as disapproval.
This publication is designed to provide accurate and authoritative information in regard to the subject matter covered.
Every attempt has been made to ensure accuracy at the time of publication; however, please note that laws, regulations,
and standards are subject to change. Please also note that some of the examples in this publication are specific to the
laws and regulations of the locality of the facility. The information and examples in this publication are provided with the
understanding that the publisher is not engaged in providing medical, legal, or other professional advice. If any such
assistance is desired, the services of a competent professional person should be sought.
Joint Commission Resources, Inc. (JCR), a not-for-profit affiliate of The Joint Commission, has been designated by The
Joint Commission to publish publications and multimedia products. JCR reproduces and distributes these materials
under license from The Joint Commission.
All rights reserved. No part of this publication may be reproduced in any form or by any means without written
permission from the publisher.
Requests for permission to make copies of any part of this work should be sent to
permissions@jcrinc.com
ISBN: 978-1-59940-997-9
For more information about Joint Commission Resources, please visit http://www.jcrinc.com.
Printed in the USA 5 4 3 2 1
CONTENTS
TARGET REVIEW ASSESS COMMUNICATE EDUCATE REPORT
Accreditation Programs/Settings
OME
AHC
BHC
CAH
NCC
OBS
HAP
LAB
INTRODUCTION...................................................................................................................................... 1
Tracer Questions Spreadsheet
SECTION 2: LEADERSHIP
2.1: Leadership in Performance Improvement................................... .... .... .... ... .... .... .... ........ 25
2.2: Safety Culture............................................................................. .... .... .... ... .... .... .... ........ 26
2.3: Patient Flow...................................................................................................... ................................... 27
2.4: Contracted Services................................................................... .... .... .... ... .... .... .... ........ 28
OME
AHC
BHC
CAH
NCC
OBS
HAP
LAB
4.14: Chemotherapy........................................................................... ........... .... ........................ ........ 63
4.15: Restraint and Seclusion............................................................. .... .... .... .......... ........... ........ 65
4.16: Youth Addiction Program.................................................................. ................................................. 66
4.17: Advanced Directives................................................................. .... .... .... .......... .... .... ........ 67
4.18: Patient Education, Communication, and Rights......................... .... .... .... .......... .... .... ........ 68
OME
AHC
BHC
CAH
NCC
OBS
HAP
LAB
9.6: Medical Equipment..................................................................... .... .... .... ... .... .... .... ...... 134
9.7: Utility Systems............................................................................. .... .... .... ... .... .... .... ...... 137
9.8: Construction................................................................................ .... .... .... ... .... .... .... ...... 141
9.9: EM Plans/Emergency Operations Plan........................................ .... .... .... ... .... .... .... ...... 144
9.10: Communications and Community in Emergencies.................... .... .... .... ... .... .... .... ...... 145
9.11: Emergency Response Exercises............................................... .... .... .... ... .... .... .... ...... 147
9.12: Disaster Volunteers................................................................... .... .... .... ... .... .... .... ...... 148
9.13: Fire and Smoke Protection Features.......................................... .... .... .... .......... ........... ...... 149
9.14: Means of Egress....................................................................... .... .... .... .......... ........... ...... 152
Tracers, tracers, tracers. Whether you’re new to the world of The Joint Commission
or a veteran of accreditation surveys, you’ve most likely heard about tracers and
you may even have a pretty good concept of what a tracer is—particularly if you’ve
been through a survey. But if not, this book includes an introduction to tracers and
mock (practice) tracers (see pages 9 and 10). This introduction tells you the purpose
of this book and how to use it as well.
You may already have a mock tracer form that you use regularly, but this book
includes a digital mock tracer form you may want to try for your mock tracers.
The next few pages explain how to use the provided tracer questions and the form.
Step 1: Select the Tracer Questions Step 3: Insert Tracer Questions into the Form
Review the provided tracer questions you’re interested in Copy and paste your selected tracer questions into the
using. Next to each question are check boxes. For each mock tracer form—in whatever order seems appropriate to
question you want to use, check one of the boxes, you. Remember that you may not ask all of the questions
indicating Use Question As Is or Adapt Question For Use. and you may ask them in different order once you are
actually conducting the tracer. You may want to leave
• Option A – Paper First: Mark your selections and
some blank tracer question blocks so you can add any
changes on paper first by printing out the question
other questions you ask as you go. Save this form with the
set (or photocopying it from the print version of the
name and date of your intended tracer.
book if you have that). Then make any of your
changes electronically in the downloaded digital
Step 4: Using the Mock Tracer Form
version of the questions.
Now you’re ready to go. You may use the form in one of
• Option B – Digital Only: Download the digital version two ways:
of the questions. Electronically mark the selection
• Option A – Paper First: Print out the form and take it
boxes and make any of your changes as you select
with you on the mock tracer, marking compliance and
questions.
comments on paper. Later, input the information into
the electronic form, adding a plan of action or other
Step 2: Download the Mock Tracer Form
information. Save the form for data collection,
The mock tracer form is available to download in color and
analysis, and reporting.
black and white. Both the color version (see page 5) and
the black and white version (see page 6) include the • Option B – Digital Only: Take your ready mock tracer
SAFER™ Matrix in the format used by surveyors to record form with you on your electronic mobile device as you
compliance. Both versions include a header to add conduct the tracer, marking compliance and comments
information about your planned mock tracer and sections electronically. As with Option A, you can add a plan or
to add tracer questions, record compliance, and suggest a action or other information later, before saving the
plan of action in response to the compliance level. You can form for data collection, analysis, and reporting.
add or delete the blank tracer question blocks, as needed.
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 16
Tracers rarely take a straight route. The surveyor diverges Goals for all tracers: Reasons for conducting tracers
onto new paths while following opportunities for are a reflection of both survey and organization goals.
investigation. It may require several tracers to cover The following outcomes are the goals of all tracers:
everything. Surveyors can visit—and revisit—any area of
• An integrated and cross-sectional review of areas that
the organization related to the care of the patient or the
are most critical to safe, high-quality care
functioning of a system.
• A focused analysis of compliance with standards
• Specific information about the organization that can
be used to design and target improvements
All the information gathered from a tracer during your Joint Commission or Joint
Commission (JCI) on-site survey can be used to design and target improvements
in your organization. Of course, you don’t want to wait until a survey to get this
information. You need to do regular risk assessments. Simulated—or mock—tracers
are one way to do that. This introduction to mock tracers will give the information
you need to get started. It will explain mock tracers and their purpose, when to
perform mock tracers, and mock tracer skills such as selecting a mock tracer
subject, asking tracer questions, and communicating during a tracer.
What performance improvement reports do you regularly produce for administrative and clinical
☐ ☐
leadership? Can you please provide access to the most recent data reports that were presented?
Who has responsibility and oversight for performance improvement data in your organization? ☐ ☐
How have the data assisted you with performance improvement initiatives? ☐ ☐
Has the organization ever used data in the medical equipment database to track and monitor
☐ ☐
performance? If so, how?
What is the focus of your data collection and use for this performance improvement initiative? ☐ ☐
What methods, tools, and techniques do you use to aggregate and analyze data for performance
☐ ☐
improvement initiatives?
How do you compare analyzed data to external sources for benchmarking (when possible) as well
☐ ☐
as comparing the data internally over time?
How did data analysis help you identify the problem in this performance improvement initiative? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How are your formats for data analysis designed to be easy to use, understand, and share? ☐ ☐
How do you report your performance improvement data analysis results? Who sees the reports? ☐ ☐
How do leaders use reported data to set priorities for performance improvement initiatives? ☐ ☐
How long have you been tracking these performance improvement data? ☐ ☐
If the data show excellent performance for several years, why track the data in the same way? ☐ ☐
How do you track data on areas of patient safety risk that you have deprioritized as a committee? ☐ ☐
What electronic support do you have for your performance improvement data use processes? ☐ ☐
If you are using data software, what is your contingency plan for problems with the software? ☐ ☐
How do you manage quality control records for the performance improvement data software? ☐ ☐
What kind of training and education are provided for performance improvement data users and
☐ ☐
data management staff?
How do you measure patient satisfaction using data? [N/A for LAB] ☐ ☐
What data have you been collecting on patient readmissions? How often do you share that
☐ ☐
information with leadership? [CAH, HAP, NCC, and OME only]
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
What are some current performance improvement efforts your organization is undertaking?
☐ ☐
Please select one to outline and describe.
Can you identify any projects or implementation efforts that did not achieve or sustain the
planned improvements? What was the response to these results? What lessons were learned ☐ ☐
from studying this attempt that will help inform other improvement initiatives?
What process did you follow to design and implement this project? ☐ ☐
How did this process work before the implemented initiatives? Please describe what changed as a
☐ ☐
result of the implementation.
What procedures or processes did you change to help facilitate this improvement? ☐ ☐
How do you typically implement performance improvement interventions changes? What kinds of
☐ ☐
accompanying education do you provide?
What specific monitors are you using to measure performance? How long have these monitors
☐ ☐
been in use? What do they measure?
How have you been monitoring progress on performance? What are your goals and measures of
☐ ☐
success?
What are you learning so far in performance improvement interventions underway? How do you
plan to track results? What reporting process will you follow?
☐ ☐
What types of reporting have you done for performance improvement interventions? ☐ ☐
What progress have you documented so far for performance improvement interventions? What
☐ ☐
additional measures will you consider putting in place if this initiative is successful?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How have you involved staff in contributing feedback as you planned performance improvement
☐ ☐
projects?
How have you informed staff about results of your initial pilot test(s) and any additional pilot
☐ ☐
testing and monitoring of performance improvement interventions?
What kind of response have you seen to the performance improvement initiative? How is that
☐ ☐
communicated to you?
How have patients and their families responded to the improvement project? ☐ ☐
Have you engaged patients and their families in the improvement project? How is this
☐ ☐
engagement accomplished?
What were the results of your performance improvement activities for this project? Has a new
compliance goal been set based on those results?
☐ ☐
What are your next steps in this performance improvement initiative? Are you making any
modifications to your processes?
☐ ☐
How are you maintaining the improvements from the initiative and monitoring its results? ☐ ☐
What steps are you taking to continue monitoring the performance improvement project? ☐ ☐
Has the organization taken steps to resolve any error-rate problem cited in its data? What
specifically has taken place?
☐ ☐
Please give an example of a high-risk process. What monitoring and improvement activities do
☐ ☐
you have related to that process?
What performance improvement initiatives have been taken or are in development to prevent
☐ ☐
adverse events from happening again?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Please tell me who is responsible for performance improvement activities in your organization. ☐ ☐
If
you
have
a
performance
improvement
committee,
how
does
it
function?
What
kind
of
representation
do
you
have
from
across
the
organization?
☐
☐
How
often
does
your
performance
improvement
committee
meet?
Who
else
attends
the
meetings?
What
is
the
typical
structure
of
the
meeting?
☐
☐
Do
you
network
or
collaborate
with
any
other
organization
or
performance
improvement
group
in
your
region?
☐
☐
How
do
you
stay
apprised
of
current
literature
or
best
practices
on
performance
improvement
initiatives?
☐
☐
Do
you
have
any
staff
meetings
or
training
on
performance
improvement
for
general
staff?
How
is
this
subject
introduced
during
orientation
or
ongoing
training
activity?
☐
☐
What
kind
of
training
and
ongoing
education
have
you
received
to
support
your
work
on
the
team
or
in
your
job
capacity
(as
performance
improvement
staff)?
☐
☐
What
kind
of
training
and
support
do
you
provide
to
staff
involved
in
your
improvement
processes?
☐
☐
Who
has
been
involved
in
the
process
of
designing
and
implementing
your
improvement
projects?
☐
☐
How
do
you
involve
staff
members
in
improvement
projects?
How
are
they
informed
about
them?
How
are
physicians
and
other
practitioners
involved
in
the
project?
☐
☐
How
do
you
familiarize
staff
members
with
changes
that
are
part
of
performance
improvement
interventions?
How
do
you
secure
their
engagement
in
the
effort?
☐
☐
What
is
the
role
of
medical
staff
in
performance
improvement
activities,
especially
in
relation
to
setting
priorities?
[CAH
and
HAP
only]
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How do you become aware of the need for a performance improvement initiative? ☐ ☐
What happens after your organization identifies a near miss? Is a root cause analysis performed? ☐ ☐
Have
you
ever
used
failure
mode
and
effects
analysis
(FMEA)
in
your
performance
improvement
work?
If
so,
please
explain
how
this
was
done
and
share
the
documentation
of
this
process.
☐
☐
In
what
areas
of
operation,
clinically
or
administratively,
do
you
think
you
might
need
to
improve
performance?
Why?
What
measures
might
you
use
to
evaluate
performance
in
those
areas?
☐
☐
Once
data
is
analyzed,
how
do
you
make
sure
that
those
who
need
to
know
the
results
are
informed?
☐
☐
What is your reporting process? What reports do you produce? Who receives them? ☐ ☐
How often does your organization update and review performance improvement reports? ☐ ☐
How
are
you
tracking
progress
on
your
performance
improvement
projects
and
communicating
results?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
How
does
your
governing
body
make
sure
that
performance
improvement
activities
reflect
your
organization’s
structure,
involve
all
departments
and
services,
and
include
services
provided
☐
☐
under
contract?
How
have
the
leaders
aligned
performance
activities
to
support
the
organization’s
mission,
vision,
☐
☐
and
goals?
How
have
the
leaders
set
priorities
for
performance
improvement
activities
and
patient
health
☐
☐
outcomes?
Have
the
leaders
given
priority
to
high-‐volume,
high-‐risk,
or
problem-‐prone
processes
for
☐
☐
performance
improvement
activities?
What
is
one
example
where
leaders
reprioritized
performance
improvement
activities
in
response
☐
☐
to
changes
in
the
internal
or
external
environment?
How have leaders assured that performance improvement occurs across the organization? ☐ ☐
Do
leaders
provide
governance
with
annual
written
reports
on
the
following?
• All
system
or
process
failures
• The
number
and
type
of
sentinel
events
☐
☐
• Whether
the
individual
served
and
the
families
were
informed
of
the
event
• All
actions
taken
to
improve
safety
both
proactively
and
in
response
to
actual
occurrences
How
have
leaders
designed
communication
structures/methods
to
meet
the
performance
☐
☐
improvement
needs
of
internal
and
external
users?
How
have
leaders
provided
the
resources
required
for
communication,
based
on
the
performance
☐
☐
improvement
needs
of
patients,
the
community,
physicians,
staff,
and
management?
How
have
leaders
evaluated
the
effectiveness
of
communication
methods
for
performance
☐
☐
improvement
purposes?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
How do leaders evaluate the culture of safety and quality? What types of tools are used for this
☐ ☐
evaluation? How often do you repeat the evaluation?
Do leaders prioritize and implement changes identified by a culture of safety evaluation? If so, can
☐ ☐
you provide an example?
Does your organization embed safety culture training into performance improvement projects
☐ ☐
and organizational processes to strengthen safety systems? If so, can you provide an example?
Does your organization use clear, just, and transparent risk-based processes for recognizing and
☐ ☐
distinguishing human errors and system errors from unsafe, blameworthy actions?
Does your organization have policies that support safety culture and the reporting of adverse
events, close calls, and unsafe conditions? If so, how are these policies enforced and ☐ ☐
communicated to all staff?
What do you do to recognize staff who have suggestions for safety improvement? ☐ ☐
Does your organization have a code of conduct or other type of policy addressing appropriate
☐ ☐
behavior? What types of conduct are defined in it?
What is the organization’s process for addressing and managing behaviors that undermine a
☐ ☐
culture of safety, such as disruptive or intimidating behavior?
How are incidents involving violations of the code of conduct handled when they occur? ☐ ☐
Do leaders adopt and model appropriate behaviors and champion efforts to eradicate
☐ ☐
intimidating behaviors? Please provide an example.
How does your organization define a patient safety event? How does that definition guide your
☐ ☐
patient safety program and safety culture?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Please describe your own processes to manage patient flow. What are your goals in relation to
☐ ☐
patient flow?
Which staff is involved in conferring on patient flow? How are staff on different units or
☐ ☐
departments involved in patient flow processes or improvement efforts?
What oversight structure (such as a team or committee) do you have in place to manage patient
☐ ☐
flow? How is oversight data monitored and reported back to leadership?
What data collection processes do you have in place to track and monitor patient flow? ☐ ☐
What reports or dashboard data do you review that help you monitor and mitigate patient flow
☐ ☐
issues that might occur on the various units and over time?
What processes do you have in place to manage and respond to boarding? Do your processes
☐ ☐
include a time limit on boarding?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
What
services
do
you
use
from
contracted
providers?
Pharmacy?
Laundry?
Environmental
Services?
Who
is
responsible
for
management
and
oversight
of
these
contracted
services
for
your
☐
☐
organization?
What is the role of leadership in relation to contracted services? ☐ ☐
Please show me a copy of a contract for outside services. How is the contract managed? ☐ ☐
What
is
the
process
leaders
use
to
set
organization
expectations
for
performance
of
contracted
☐
☐
services?
Please
give
an
example.
What
is
the
process
leaders
use
to
evaluate
contracted
services
per
organization
expectations?
☐
☐
Please
give
an
example.
Please
give
an
example
that
describes
how
leaders
took
steps
to
improve
contracted
services
that
☐
☐
did
not
meet
expectations.
What
performance
criteria
for
contracted
staff
are
set
in
advance?
How
do
you
monitor
☐
☐
performance?
How
is
performance
evaluated
and
by
whom?
What
kinds
of
orientation
and
training
do
you
provide
to
contracted
staff?
Where
do
you
☐
☐
document
this
education?
How
are
you
addressing
the
oversight
of
contracted
staff
supplied
by
organizations
that
are
also
☐
☐
accredited
by
The
Joint
Commission?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
What is the content of the orientation you provide for staff? How do you provide the orientation?
☐ ☐
How is this documented?
What topics were covered in recent training? How was the training provided? ☐ ☐
What education resources and opportunities are available to you for professional development? ☐ ☐
Do you feel that the organization’s training and education adequately prepare you for preventing
☐ ☐
adverse events? Do you know how to respond to an adverse event and other incidents?
What kind of orientation and training do you provide to contracted staff? Where do you
☐ ☐
document this?
What training is provided for leaders regarding organization policy and compliance with
regulatory requirements?
☐ ☐
What kind of training and orientation is provided to staff providing care, treatment, and services
☐ ☐
to children, youth, and geriatric individuals?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Who is responsible for performing your credentialing? Do you use a credentials verification
☐ ☐
organization (CVO) for verification? If so, how do you evaluate the services of the CVO?
When are practitioner licenses and other credentials verified? How is this process documented? ☐ ☐
What sources do you use to verify a practitioner’s education, training, and licensure? How do you
☐ ☐
perform your primary and secondary source verification?
Do you require specific health screenings for credentialing? What about proof of immunizations?
☐ ☐
Is any other health information required?
What is the process for recredentialing? How does the recredentialing process differ from the
☐ ☐
initial credentialing process?
Do you have a different process to verify the credentials of nonprivileged practitioners (if you
☐ ☐
choose to credential)? Can you please describe that process?
Please provide the credentialing files for your licensed independent practitioners. ☐ ☐
What is your process for granting initial clinical privileges to practitioners? Is the process approved
☐ ☐
by leadership?
Does the process for granting renewed or revised privileges differ from the process for granting
☐ ☐
initial privileges? If so, how?
Do you have an expedited process for initial appointment and reappointment to the medical staff
☐ ☐
and for granting privileges? Can you please describe that process? [HAP only]
How is the medical staff involved in the privileging process? [CAH and HAP only] ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What criteria do you use to determine the scope of the practitioner’s privileges? ☐ ☐
How do you know if practitioners are credentialed and trained for privileges requested? ☐ ☐
What evidence do you use to determine a practitioner’s current ability to perform the privileges
☐ ☐
requested? How is this documented?
What else is evaluated before granting initial, renewed, or revised privileges to a practitioner for
☐ ☐
requested privileges? How is leadership involved in this evaluation?
Is there a time constraint on resources needed to support granting of requested privileges? If so,
☐ ☐
please explain what that is. [CAH and HAP only]
How do you notify practitioners about decisions to grant, renew, or deny privileges? ☐ ☐
Is there a time limit for notifying practitioners about decisions regarding requested privileges?
☐ ☐
How is that determined? [CAH and HAP only]
Does your organization grant temporary privileges? If so, for what reasons? For how long? What is
☐ ☐
the process?
Please provide the documentation showing the practitioner’s credentials and training for the
☐ ☐
privileged procedures.
How are performance evaluations factored into maintaining, renewing, revising, or revoking
☐ ☐
privileges?
How does your organization evaluate each practitioner’s performance on an ongoing basis? What
does your organization do if issues affecting the provision of safe, high-quality patient care are ☐ ☐
identified? [CAH and HAP only]
What is the role of the medical staff in responding to reported concerns about the clinical
☐ ☐
competence of a privileged practitioner? [CAH and HAP only]
What is your fair hearing and appeal process for addressing denial, suspension, revocation,
☐ ☐
reduction, and reappointment of privileges?
What continuing education have privileged practitioners participated in recently? Can you please
☐ ☐
provide documentation of this? [CAH and HAP only]
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
What
processes
do
you
have
in
place
for
competency
assessment?
How
are
these
processes
☐
☐
documented?
What structure do you have in place to oversee your competency assessment processes? ☐ ☐
What
qualifications
and
competencies
are
required
for
staff
who
are
responsible
for
performing
competency
assessments?
How
do
you
assess
the
competency
of
those
staff
to
perform
☐
☐
competency
assessments?
How often is competency assessed? When do you first assess competency? ☐ ☐
How does the organization verify competency? How is verification of competency documented? ☐ ☐
How
do
you
conduct
internal
audits
of
your
policies
and
procedures
relating
to
staffing
☐
☐
competency?
How
do
you
ensure
that
your
competency
assessment
processes
meet
all
regulations
and
☐
☐
requirements?
What types of skills are you evaluated on for your job? ☐ ☐
How does your organization assess the competency of those who work with equipment? ☐ ☐
Would
you
please
show
me
a
personnel
record
for
a
staff
member
who
has
undergone
☐
☐
competency
training
for
operating
a
specific
piece
of
equipment?
What
competencies
does
the
organization
require
of
those
who
provide
care,
treatment,
and
services
for
children
and
youth?
Can
you
show
me
where
this
is
documented
in
the
personnel
☐
☐
record?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What
types
of
data
do
you
collect
to
inform
your
ongoing
professional
practice
evaluation
☐
☐
(OPPE)?
How
is
this
analyzed
and
tracked?
[CAH
and
HAP
only]
What
do
your
policies
specify
regarding
focused
professional
practice
evaluations
(FPPEs)?
[CAH
☐
☐
and
HAP
only]
When
do
focused
professional
practice
evaluations
(FPPEs)
occur
and
why?
How
is
the
FPPE
time
☐
☐
period
determined?
[CAH
and
HAP
only]
Who
is
responsible
for
creating
the
focused
professional
practice
evaluations
(FPPEs)
plan?
[CAH
☐
☐
and
HAP
only]
Who fills out the focused professional practice evaluations (FPPEs)? [CAH and HAP only] ☐ ☐
What
supportive
mechanisms
do
you
have
in
place
to
respond
when
an
FPPE
or
OPPE
warrants
it?
☐
☐
[CAH
and
HAP
only]
May
I
please
see
examples
of
OPPEs
and
FPPEs?
[CAH
and
HAP
only]
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
When a patient is admitted, what members of the staff are involved? How are patients and
☐ ☐
families involved in the process? [N/A for AHC and OBS]
What methods are used to identify the patient during the registration process? ☐ ☐
What education and/or information do you provide to patients at admission and/or in the initial
screening/assessment? How do you ensure and confirm that the patient and family understand ☐ ☐
what you share with them at that time?
How do you document the registration/admission? How do you document the education and/or
information provided to patients at that time? What do you do for a patient that is non-English ☐ ☐
speaking?
What is your registration or check-in process for surgery? Is a learning assessment performed? Do
you perform any presurgical assessments of the patients? If so, what are they? [CAH, HAP, OBS ☐ ☐
only]
If the patient presents at admission with any high-risk factors, such as diabetes or self-harm, what
☐ ☐
additional assessments are performed or ordered for referral, if any?
Does your physical space for admission permit privacy? How to you mitigate if admission is
☐ ☐
conducted in a noisy, busy area?
What is your discharge planning process? When does discharge planning begin? Who is involved? ☐ ☐
What kind of role do you play in the patient’s discharge planning? Are you included in the
interdisciplinary patient care team meetings?
☐ ☐
What kind of discharge planning do you have in place for patients receiving behavioral health
☐ ☐
care, particularly in relation to any medications after discharge?
What is the discharge plan for this patient? Is it documented? Please provide this patient’s
☐ ☐
discharge plan.
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
How have you informed and involved the patient and family in the discharge plan? How do you
accommodate any questions or concerns? How do you ensure and confirm that patients and ☐ ☐
family members understand what you share with them during discharge planning?
What information, education, and material do you provide to the patient at discharge? How do
☐ ☐
you know the patient understands what you provided?
Patient: Please tell me about your experience with discharge. Can you tell me when you need to
follow up on, how to take your medications, and what type of activity you can or cannot do? Did ☐ ☐
you have enough information when you left? Were you able to have your questions answered?
How do you follow up with patients after they are discharged? How do you ensure and confirm
☐ ☐
that patients understand what you share with them during follow-up?
What data do you receive about discharged patients? What is the rate of returns to your hospital
within 30 days of discharge? How do you track patients who go to a different hospital within 30 ☐ ☐
days of discharge? [CAH and HAP only]
What do you do with data on readmissions to your hospital? How do you report it and to whom?
☐ ☐
[CAH and HAP only]
Who is involved in ensuring safe transition of a patient to a new location, home, or another
☐ ☐
organization? Please describe the handoff communications process.
How do staff members educate the patient and family about transition home or to a different
facility? How do you ensure and confirm that patients and family members understand what you ☐ ☐
share with them at that time?
What is your process for transferring a patient to a higher level of care? What is communicated to
the next provider of care? What is your process and policy on calling 911–EMS (emergency ☐ ☐
medical services) system and/or a private ambulance?
How do you refer a patient to a hospital? What information do you communicate to the hospital?
How is this information communicated? [N/A for CAH and HAP]
☐ ☐
What kind of interaction do you have with local hospitals and/or long-term care facilities to better
☐ ☐
communicate issues that may result in hospital readmissions? How effective is this interaction?
Please explain the process for making the decision to send a patient to the emergency
☐ ☐
department. [N/A for CAH and HAP]
How do you receive patients from the emergency department? What kind of information do you
receive? How is this information communicated to you? How do you know what must be set up in ☐ ☐
the patient’s room prior to transfer? [CAH and HAP only]
What kind of referral or discharge information do you receive for a new individual transferred to
☐ ☐
your organization? What materials or guidance was the previous organization able to provide?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
How are referrals made for additional care and services, such as for ongoing opioid addiction
treatment or home health care? How are referrals documented? How are patients informed and
☐ ☐
educated about the referrals? How do you ensure and confirm that patients understand that
information?
Please explain how you mitigate any potential issues during transitions of care and if an issue
requires immediate response. How do you factor such issues into your transitions of care ☐ ☐
processes?
How do you educate and train staff on admission, discharge, and transitions of care processes?
☐ ☐
How often do you provide staff with updates on these processes?
* The term admission and its forms (admit) is also used to indicate any initial point of contact such as registration,
acceptance into a program, beginning of services, and so on. You may change the terms to any that are more appropriate
for your organization.
† The term discharge and its forms (discharging) is used to indicate any point of contact at the end of an episode of care,
including transfer. You may wish to use the phrase continuity of care or other terms that are more appropriate for your
organization.
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
Please show me a copy of your organization’s policies for screening and assessing patients for
☐ ☐
each service you provide.
How do you determine which screenings/assessments you will perform? How is this written into
your policies and what processes do you have in place to review and, if necessary, update those ☐ ☐
policies?
What is your process for conducting screenings/assessments? How often are they performed? ☐ ☐
How do you communicate results of screenings/assessments with the rest of the interdisciplinary
☐ ☐
treatment team?
Can the results of a screening trigger a referral or a full assessment? How would a member of the
treatment team communicate the need for this comprehensive assessment to the appropriate ☐ ☐
team member?
Do you ever conduct any specialized or specific additional screenings/assessments for patients? If
☐ ☐
so, what are they? Where do you document these screenings/assessments?
What are your time frames for completion of initial screenings/assessments and how do you
☐ ☐
communicate results with staff?
What is your process for screening/assessing a new patient? How do you document the
☐ ☐
screening/assessment?
What kinds of assessments do you conduct when a patient arrives on the medical/surgical unit?
☐ ☐
Who conducts these assessments? [CAH and HAP only]
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
Please describe the initial screenings/assessments that you conducted for this patient. What kind
of ongoing assessment do you conduct for patients?
☐ ☐
How are behavioral health patients assessed when admitted through the emergency department
(ED)? When patients transition to another area of the hospital from the ED, how is this handled ☐ ☐
and documented? [CAH and HAP only]
Does your organization perform any specialized types of screenings/assessments for specific
☐ ☐
populations, such as pediatric or geriatric patients?
How do you assess patients who may have dementia? What reassessments do you conduct? ☐ ☐
How do you coordinate and document the assessment of a new hospice patient? What processes
☐ ☐
do you have in place to ensure timely assessment and documentation? [OME only]
Who is on your interdisciplinary team? How is it structured to support the care, treatment, and
☐ ☐
services your organization provides?
What role does the referring physician have on the interdisciplinary team? How do you
☐ ☐
communicate with the referring physician?
What kind of involvement have you had in the plan of care for this patient? How is this
☐ ☐
involvement documented?
How often does each interdisciplinary team meet? How and where are its activities documented? ☐ ☐
How do you update and modify the plan of care, treatment, and services? Who monitors it? How
☐ ☐
is this documented?
Can you tell me about the plan of care for this patient? What kinds of patient activities are you
required to do in order to implement this plan of care? How often do you review and update a ☐ ☐
care plan for a patient receiving this type of care?
What is the process you follow when your patient’s status changes? As an example, can you tell
me what happened the last time your patient’s status changed? How did you communicate this to ☐ ☐
others on the care plan team?
How are care, treatment, or service plans developed? What information is included in the plan
☐ ☐
reviews? [BHC only]
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
What model does your organization use for developing care, treatment, or service plans and
tracking progress? What information is recorded in the progress notes? How has the
☐ ☐
documentation system been revised to reflect the care, treatment, or service plan model? [BHC
only]
How do care, treatment, or service team members communicate with one another regarding the
☐ ☐
care, treatment, or service plan as well as updates to the plan? [BHC only]
Does the care, treatment, or service plan reflect the individual’s needs, strengths, references, and
☐ ☐
goals? Who contributes to the plan? [BHC only]
How does the care, treatment, or service plan team monitor the individual’s progress toward
goals? What measure of a successful clinical outcome has been identified for individuals? [BHC ☐ ☐
only]
What strengths and outcomes does the care, treatment, or service plan team expect to see for
☐ ☐
each individual? What happens if an individual is not meeting expected outcomes? [BHC only]
What do you define as care, treatment, or service plan outcomes at your organization? How do
you evaluate whether you are achieving outcomes for individuals served, as well as for all ☐ ☐
individuals served in the aggregate? [BHC only]
What kind of interdisciplinary work do you undertake when planning care, treatment, or service
☐ ☐
for a youth? Who is involved? How is this documented? [BHC only]
How do you involve the youth and parents in the care, treatment, or service plan process? How
☐ ☐
are teachers involved? What do you communicate and when? [BHC only]
How has the youth adapted to the care, treatment, or service plan? Have you had to make any
☐ ☐
adjustments? If so, may I see documentation of that? [BHC only]
What is the response to violent behavior by the youth? How does this impact the care, treatment,
☐ ☐
or service plan, if at all? [BHC only]
What is the process for the physical therapy department to receive orders for a patient? How is
physical therapy staff informed about a patient’s plan of care? How do you coordinate the plan of
care with the floor? How do you also communicate with practitioners regarding
☐ ☐
recommendations and treatment plans? [N/A for BHC]
Physical Therapist: Are you included in the interdisciplinary patient care team meetings? What
☐ ☐
kind of role do you play in the patient’s discharge planning? [N/A for BHC]
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
What kinds of screenings and assessments do you perform in the emergency department?
Do you use protocols and/or standing orders? How are these developed and maintained? Are
they reviewed annually and signed off by the medical executive committee?
☐ ☐
What information does the emergency department provide when transferring a patient to
☐ ☐
another department in the organization or to other organizations? How is this documented?
Have admission backups in the emergency department been a problem? If so, how are you
☐ ☐
addressing that?
What kinds of communication processes do you have in place to help the hospital address an
☐ ☐
upsurge in patients coming into the emergency department?
How do you educate and inform the patient and family about what will happen in the emergency
☐ ☐
department regarding a patient’s care?
How do you make certain the patient and family understand what is happening in the emergency
department during the patient’s visit?
☐ ☐
How does the emergency department interface with the radiology department when an x-ray is
☐ ☐
needed?
How do you communicate a stat test order from the emergency department to the laboratory?
☐ ☐
What follow-up do you need to do?
What is the process to deliver a sample to the laboratory from the emergency department? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
Are verbal orders used in situations other than an acute emergency? What is the process for
☐ ☐
obtaining, documenting, and implementing a verbal order?
Have you identified any issues in communication among staff and between departments? What
type of data have you collected to help determine the extent and cause of these issues? What ☐ ☐
changes have you made to mitigate these issues?
How does the hospital provide patient flow data to the Centers for Medicare & Medicaid Services
☐ ☐
(CMS) on its inpatient emergency department measures?
* HAP standards related to pain assessment and management (namely, PC.01.02.07) are undergoing revision at the time of
this printing, so pain management questions have been eliminated here. Check the forthcoming HAP manuals for correct
relevant standards and adapt tracer questions to the new standards as necessary.
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
What methods or criteria do you use to screen patients at risk for suicide? ☐ ☐
What questions do you ask to screen patients at risk for suicide? What criteria are used to decide
☐ ☐
whether to conduct a full assessment? How does that assessment differ from the screening?
When do you conduct suicide risk screenings and assessments? How are they documented? What
☐ ☐
do you do when potential risk factors are identified?
If a patient reports previous suicide attempts, how are those attempts and their triggering events
☐ ☐
evaluated? How are the reports documented?
How are patients reassessed for suicide risk during their treatment? ☐ ☐
What training do emergency department and medical/surgical staff receive in relation to suicide
☐ ☐
risk assessment and prevention? [HAP only]
What is the competency of staff to complete the suicide risk screening? What is the competency
☐ ☐
of staff to conduct a full assessment? May I see competency documentation?
Can you describe your process to prevent suicide among the individuals you serve? For example,
☐ ☐
what kinds of interventions do you employ for individuals at risk for suicide?
During discharge, how do you communicate community resources for those at risk for suicide? ☐ ☐
Have you planned any improvements relating to suicide risk assessment and prevention? Who is
involved in this planned improvement project? What will you do to help implement and monitor ☐ ☐
improvements?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Can you please explain your process for performing pain assessment? How is this documented? ☐ ☐
How do you assess pain in the pediatric patient, the patient with cognitive disabilities, the patient
who is physically challenged, the patient with sensory or verbal deficiencies, and non-English- ☐ ☐
speaking patients?
How do you perform initial assessment for pain? When does this occur? ☐ ☐
Please tell me your process to document assessment and care planning in relation to ongoing pain
☐ ☐
management. How is this communicated to staff?
In addition to medication management, what other pain management techniques are used? ☐ ☐
What kind of pain management have you been providing for this patient? How do you assess for
☐ ☐
pain management in an ongoing manner?
Patient: Have you been assessed for pain? How often does the staff do this assessment? Is your
☐ ☐
pain being managed well? Please explain why or why not.
Patient: How well do you understand the care that you have been provided, such as medications
☐ ☐
and pain management? What do you do if you have a question about your care?
Have you educated patients and family about the pain management process and treatment
☐ ☐
options? How is this education done?
Patient and Family: What information have you been given about pain assessment and pain
☐ ☐
management?
Please describe what you know about the cultural aspects of pain expression and management. ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What improvement efforts are you undertaking regarding the organization’s approach to pain
☐ ☐
management? Have you made improvements? How do you know?
* HAP standards related to pain assessment and management (namely, PC.01.02.07) are undergoing revision at the time of
this printing, so application of pain management standards questions for HAP have been eliminated here. Check the
forthcoming HAP manuals for correct relevant standards and adapt tracer questions to the new standards as necessary.
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Please
provide
a
copy
of
your
organization’s
policy
and
procedures
for
addressing
possible
trauma,
abuse,
neglect,
or
exploitation
of
a
patient.
☐
☐
What
criteria
do
you
use
to
identify
who
may
be
a
victim
of
trauma,
abuse,
neglect,
or
exploitation?
When
is
an
assessment
performed?
How
is
this
documented?
☐
☐
How does your assessment process address past trauma, abuse, neglect, or exploitation? ☐ ☐
If
the
patient
reports
a
history
of
trauma,
abuse,
neglect,
or
exploitation,
what
sort
of
follow-‐up
is
conducted?
☐
☐
To
whom
would
you
communicate
suspicions
of
trauma,
abuse,
neglect,
or
exploitation?
How
would
you
report
this?
When
would
you
file
a
report
of
abuse,
neglect,
or
exploitation
with
your
☐
☐
local
agency?
Please
describe
your
understanding
of
the
signs
and
symptoms
of
abuse
or
neglect.
Do
you
use
any
specific
tools
or
guidelines
to
assist
in
the
assessment
process?
☐
☐
What
specific
training
have
you
received
in
recognizing
signs
and
symptoms
of
abuse
or
neglect?
May
I
review
the
training
materials?
☐
☐
How
is
competency
in
the
assessment
of
abuse,
neglect,
or
exploitation
evaluated?
How
often
is
this
done?
☐
☐
How
has
trauma-‐informed
care
training
been
incorporated
into
the
assessment
or
treatment
process?
May
I
see
documentation
of
that
training?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
4.7:
Nutrition
Relevant
Standards:
CTS.04.01.03,
CTS.04.02.16,
CTS.04.03.33,
HR.01.05.03,
HRM.01.05.01,
Use
Adapt
PC.01.02.01,
PC.02.02.03,
PC.02.03.01,
RC.02.01.11,
RC.02.04.01
Question
Question
As
Is
for
Use
Accreditation
Programs/Settings:
AHC,
BHC,
CAH,
HAP,
NCC,
OME
NOTE:
CTS
and
HRM
standards
are
for
BHC
only.
Do you have a process for nutrition screenings/assessments? What is that process? ☐ ☐
Please
tell
me
about
the
ongoing
treatment
and
services
provided
to
the
patient,
such
as
nutrition
education
and
counseling.
☐
☐
How do you plan menus for patients with certain dietary concerns? [N/A for AHC] ☐ ☐
What
are
the
potential
barriers
to
this
patient’s
following
the
recommended
diet?
How
did
you
address
these
barriers?
☐
☐
How do you address the different religious and cultural dietary customs of patients? ☐ ☐
What
do
practitioners
do
to
address
a
patient’s
weight
loss?
What
changes
are
made
to
a
patient’s
diet
to
encourage
weight
gain?
Where
are
the
effects
of
those
changes
documented?
☐
☐
How
does
the
staff
prepare
to
care
for
a
total
parenteral
nutrition
(TPN)
patient?
[N/A
for
AHC
and
BHC]
☐
☐
How
is
the
total
parenteral
nutrition
(TPN)
currently
being
provided
to
the
patient?
[N/A
for
AHC
and
BHC]
☐
☐
Please describe the total parenteral nutrition (TPN) process. [N/A for AHC and BHC] ☐ ☐
Please
describe
your
staff
training
and
experience
with
total
parenteral
nutrition
(TPN).
May
I
see
documentation
of
your
certification
in
total
parenteral
nutrition
(TPN)?
[N/A
for
AHC
and
BHC]
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Do
you
always
assess
the
patient
for
skin
and
pressure
ulcer
risk?
If
so,
when?
How
is
the
assessment
documented?
☐
☐
What
is
your
process
to
assess
skin
and
wounds
for
potential
pressure
ulcers
or
other
complications?
Do
you
use
any
evidence-‐based
guidelines
or
tools?
If
so,
may
I
see
them?
☐
☐
How is the staff educated and trained to perform skin and pressure ulcer assessments? ☐ ☐
If
you
use
a
wound
care
specialist,
what
role
does
that
person
play
in
your
assessment
and
plan
of
care
process?
☐
☐
How
do
you
communicate
any
concerns
about
skin
and
pressure
ulcers
issues
during
assessment?
What
type
of
escalation
do
you
normally
plan
for?
☐
☐
How
do
you
collect
data
on
skin
and
pressure
ulcer
rates?
What
do
you
do
with
that
data?
Has
the
data
led
to
any
improvements?
If
so,
what?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
What is the process for assessing a patient for falls risk? What ongoing fall assessments and
☐ ☐
reassessments do you conduct?
What criteria are used for a falls risk designation? What else can trigger a falls risk designation? ☐ ☐
What interventions do you put in place when a patient is designated a falls risk? ☐ ☐
How are any changes in the patient’s condition considered in a falls re-evaluation? ☐ ☐
What kind of education do you provide to patients and families about falls risk and prevention? ☐ ☐
Patient: You have been designated as a falls risk by the nursing facility. Do you understand what
☐ ☐
that means? Do you understand why the staff has put certain interventions in place?
Patient: Do you understand why you have been determined to be a falls risk? Do you understand
what that means? Have staff members been responsive to your needs?
☐ ☐
How are staff members trained in falls risk and prevention? How often is that training provided? ☐ ☐
What interventions do the staff carry out to reduce falls? How are these actions documented? ☐ ☐
Staff Member: What orientation and training have you received regarding fall prevention? ☐ ☐
Staff Member: How do you respond if a patient falls? How is the fall reported and documented? ☐ ☐
Staff Member: How do you prevent yourself from falling while assisting a patient during a fall? ☐ ☐
Nurse Leader: What do you as a manager do to prevent patient and employee falls? ☐ ☐
Staff Member: How are you informed that a patient is at risk for falls? ☐ ☐
What is the process for preventing a fall during transport? What is the process for informing other
☐ ☐
units or organizations of a falls risk?
How do you assess the home environment for falls risk? How do you reassess the environment for
☐ ☐
falls risk on returning home visits?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What falls risk interventions have you put in place in the home environment? ☐ ☐
Family Caregiver: How have you been educated about falls risk? Do you understand why you have
☐ ☐
been asked to make changes in the home? Do you understand what constitutes a falls risk?
When physical therapy staff members visit the home, what types of falls risk reduction activities
☐ ☐
do they carry out?
What environmental controls does the organization have in place to prevent falls? What do you
☐ ☐
do if that technology fails?
Does the organization examine environmental risks regarding falls during environmental tours? ☐ ☐
Staff Member: What do you do when you see an environmental risk for falls, such as a spill? ☐ ☐
Has the organization done a root cause analysis on environmental risks for falls? ☐ ☐
Does the organization monitor data regarding falls and the causes thereof—for example,
☐ ☐
inclement weather? If so, what has the organization discovered?
What process does the organization have to identify environmental falls risk such as slippery
☐ ☐
areas? How do you address these risks?
What types of data do you collect in relation to falls risk? How do you analyze and use these data? ☐ ☐
What do your data indicate about falls risk? Are there opportunities for improvement around fall
☐ ☐
reduction? How have the falls risk data assisted you with your agency’s improvement efforts?
If you have a falls risk reduction program, please describe it, including any recent interventions. ☐ ☐
How does your organization address the potential of certain medications to trigger falls? ☐ ☐
As part of your falls risk assessment process, do you review medication profiles? If so, why? ☐ ☐
Do you have a formal list of medications associated with falls, like blood pressure medications,
☐ ☐
sedating medications, diuretics, and analgesics—opiates and muscle relaxants in particular?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
How are patients undergoing operative or high-‐risk procedures checked in? ☐ ☐
What
kind
of
education
do
you
provide
to
patients
in
relation
to
the
procedure,
risk
factors,
and
any
postprocedural
care?
Do
you
have
any
documentation
to
accompany
this
process?
☐
☐
What is involved in the patient preoperative process? How do you obtain informed consent? ☐ ☐
What is your sedation and operative consent process? Can you show me the form you use? ☐ ☐
How
do
you
address
medication
reconciliation
prior
to
the
procedure?
What
happens
if
there
are
contraindications
for
the
patient
to
receive
the
medications
ordered?
☐
☐
How
do
you
obtain
information
prior
to
the
procedure
about
any
allergies
that
the
patient
might
have?
☐
☐
What
clinical
information
(such
as
labs
or
diagnostic
test
results)
needs
to
be
available
prior
to
the
procedure?
☐
☐
Will
you
please
describe
the
kind
of
testing
conducted
prior
to
the
procedure?
Who
monitors
these
tests?
How
are
they
documented?
☐
☐
What
interaction
and
communication
do
you
have
with
the
laboratory
in
relation
to
your
preoperative
testing
practices?
☐
☐
Do you perform any presurgical assessments of patients? If so, what are they? ☐ ☐
Please describe the preanesthesia assessment and the preanesthesia assessment policy. ☐ ☐
Please describe your presedation or preanesthesia assessment. Who performs this assessment? ☐ ☐
Did
the
patient
have
an
opportunity
to
ask
questions
about
the
procedure?
Were
his
or
her
learning
needs
met?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
How was the patient education about the procedure documented in the patient record? ☐ ☐
Was
the
information
about
the
procedure
only
provided
verbally
to
the
patient,
or
were
printed
materials
provided
as
well?
☐
☐
Patient:
What
instructions
were
you
given
regarding
preparation
for
this
procedure?
Did
you
understand
and
follow
the
instructions?
☐
☐
Patient: What did your physician tell you about how this procedure would be performed? ☐ ☐
Patient:
What
did
the
physician
tell
you
about
the
consent
form
for
the
procedure
that
you
signed?
☐
☐
Patient: What did your physician tell you about alternatives to this procedure? ☐ ☐
Where
is
your
presedation
assessment
documented
in
the
patient’s
record?
How
do
you
update
it?
☐
☐
How do you prepare patients for surgery? What kind of process do you follow? ☐ ☐
How
do
patients
get
from
the
exam
room
to
the
surgical
suite?
How
are
nonambulatory
patients
managed?
☐
☐
How and when do you identify the patient before surgery? ☐ ☐
What kind of preoperative check do you perform for the procedure? What do you verify? ☐ ☐
Do
you
use
a
preoperative
standardized
list,
and
does
it
include
documentation
regarding
the
patient’s
informed
consent?
☐
☐
What
is
your
time-‐out
process?
Please
describe
it
to
me.
Who
is
responsible
for
it?
Where
do
you
document
its
completion?
☐
☐
When was the surgical site marked? How was it marked? ☐ ☐
What is your process to verify the surgical site? How do you involve the patient in the process? ☐ ☐
What
are
the
roles
of
the
surgical
staff
at
the
start
of
the
procedure?
What
are
the
roles
of
the
surgical
staff
while
the
procedure
is
under
way?
☐
☐
How
are
medications
managed
in
the
operating
area?
Who
has
access
to
the
medication
cart
and
how
is
that
monitored
and
controlled?
☐
☐
What is your process in the event of resuscitation? How is this process documented? ☐ ☐
Who
is
responsible
for
preparing
any
postsurgical
specimens
for
pathology?
☐
☐
©
2017
The
Joint
Commission.
May
be
adapted
for
internal
use.
Page
2
of
3
What types of postsurgical assessment do you perform? When are they performed? ☐ ☐
How
is
the
patient
monitored
postoperatively?
How
is
the
patient
assessed
for
recovery
from
anesthesia?
☐
☐
Do postoperative instructions include signs and symptoms that require a call to the surgeon? ☐ ☐
What
criteria
are
used
to
assess
a
surgical
patient’s
adequate
recovery
for
discharge?
Who
is
responsible
for
making
that
decision?
☐
☐
What
kind
of
postoperative
care
was
ordered
for
this
patient?
How
are
you
kept
apprised
of
the
patient’s
condition?
☐
☐
What postoperative information and material do you provide to the patient and family? ☐ ☐
What
kind
of
education
do
you
provide
to
the
patient
regarding
home
care
and
infection
prevention?
☐
☐
Do postoperative instructions include signs and symptoms that require a call to the surgeon? ☐ ☐
When do surgery patients typically return to your organization for any reevaluation? ☐ ☐
Surgical
Staff:
What
kinds
of
competency
assessments
and
ongoing
training
have
you
received
in
relation
to
perioperative
care?
☐
☐
Please
provide
the
documentation
showing
your
physicians’
credentials
and
training
in
this
procedure.
May
I
see
the
physicians’
most
recent
evaluations
from
their
department
heads?
☐
☐
What
type
of
training
has
your
staff
received
on
the
fundamentals
and
techniques
of
endoscopy
and
moderate
sedation?
☐
☐
What
are
some
frequent
high-‐risk
procedures
performed
by
your
organization?
What
data
do
you
collect
in
relation
to
them?
What
type
of
analysis
have
you
performed?
☐
☐
What
type
of
outcome
has
an
analysis
of
data
on
your
most
common
high-‐risk
procedures
provided?
☐
☐
What
action
have
you
taken
in
response
to
data
relating
to
high-‐risk
procedures?
☐
☐
©
2017
The
Joint
Commission.
May
be
adapted
for
internal
use.
Page
3
of
3
How do you receive x-ray orders for radiological testing and procedures? How are radiology test
☐ ☐
results communicated back to the ordering provider?
How do you prepare equipment for the imaging? How is a patient transported to radiology? How
☐ ☐
is patient care managed in radiology?
How do you identify the patient to ensure that you are performing the ordered radiology test on
☐ ☐
the correct patient?
What radiation safety equipment is used to protect patients during radiological procedures and
☐ ☐
tests to minimize overexposures?
What kind of patient education do you provide about x-rays and other radiology processes? ☐ ☐
Patient: What education have you received regarding safety precautions for your radiological
☐ ☐
tests and procedures?
Patient: Describe, as best you can, the type of radiological tests and procedures you had and why. ☐ ☐
Please provide a recent assessment of delays in the radiology department. Describe the system
☐ ☐
your department has in place for prioritizing procedures in such a situation.
How do you screen patients prior to MRI testing? Do you screen staff as well? ☐ ☐
What is your process for managing patients with anxiety or claustrophobia who are set to
☐ ☐
undergo MRI testing?
What qualifications do you require for the MRI technologists? How do you verify staff
☐ ☐
qualifications?
What quality control activities do you perform on the radiology equipment to ensure that it is
☐ ☐
functioning properly?
What guidelines are the imaging protocols based upon? Who reviews and approves them? How
☐ ☐
are they kept current?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
Please describe the patient safety training that you have received at this organization regarding
☐ ☐
radiology processes.
Does your training for radiology processes include caring for non-English-speaking patients? ☐ ☐
Who interprets the radiological testing results, and how are the findings communicated to the
☐ ☐
ordering provider?
What is the process for handling radioactive source material, from delivery through
☐ ☐
administration and then disposal?
What training have you received about radioactive source material handling and preparation? ☐ ☐
How do you prepare radioactive source material? What risks are involved in preparing such
material? How do you minimize the risk of exposure? What personal protective equipment (PPE) ☐ ☐
do you wear when preparing radioactive source material?
What training have you had regarding the safe preparation of radioactive source material? ☐ ☐
How do you decide which staff members need to wear dosimetry badges? How often and by
☐ ☐
whom are the badges monitored?
Describe how you would respond to an unintended overexposure to radiation. To whom would
☐ ☐
you report such an event?
Where are the radioisotopes stored in the hot lab? Who has access to that storage area? How
☐ ☐
does the hot lab maintain the security of that storage area?
How does the hot lab keep radioisotopes secure during transportation in the organization? ☐ ☐
What are the safety and security risks associated with radioisotopes? ☐ ☐
What personal protective equipment should you wear when using or handling radioisotopes? ☐ ☐
What has your training taught you about how to use radioisotopes properly? ☐ ☐
Has the organization conducted an emergency drill related to hazards of radioisotopes? What
☐ ☐
were the results of that drill?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Please provide the laboratory policies and procedures, including those for blood transfusions.
☐ ☐
[LAB only]
How do you receive an order for blood products in the laboratory? [LAB only] ☐ ☐
May I see the transfusion order and consent form? May I observe as you confirm this transfusion
☐ ☐
order? How long can you wait before starting the transfusion?
What process do you follow to prepare and test the blood product before providing it to the
patient? How are tests documented? [LAB only]
☐ ☐
What is the process for patient identification during blood collection? How is the patient
identification retained throughout the transfusion?
☐ ☐
How can you ensure that patient information stays attached to the blood unit throughout the
☐ ☐
transfusion process?
What process do you follow to check for a transfusion reaction? How is this process documented? ☐ ☐
What would you do in the event that a patient had a transfusion reaction? ☐ ☐
What training and competency have you had in relation to handling and administering blood
☐ ☐
products?
What is the process to obtain blood in an emergency? Please give an example. [LAB only] ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How do you monitor the blood utilization and criteria for transfusion? ☐ ☐
How does your laboratory perform the quality control in the blood bank daily and document the
☐ ☐
lot numbers? Please provide your quality control documentation for review. [LAB only]
How are the blood products stored? May I see the refrigerator used for this? May I review the
☐ ☐
temperature logs? [LAB only]
What sort of backups are used on the main refrigerator and freezer, in case of power outages or
☐ ☐
other emergencies? [LAB only]
May I review the credentialing file on the new laboratory director? [LAB only] ☐ ☐
May I review the training and competency documentation for the transfusion staff and laboratory
☐ ☐
technician? [LAB only]
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
What is the process for the physical therapy department to receive orders for a patient? How is
the physical therapy staff informed about a patient’s plan of care? How do you coordinate the ☐ ☐
plan of care with the staff regarding recommendations and treatment plans?
What physical therapy are you doing for this patient? How is this care documented? ☐ ☐
When did you receive this referral? How long have you been seeing this patient? When do you
☐ ☐
report to the case manager?
What training and orientation have you received regarding hand hygiene? Can you tell me what is
☐ ☐
required?
What do you do if the patient appears to be in distress? To whom do you report it? ☐ ☐
What training and orientation have you received related to falls risk and patient safety? ☐ ☐
When physical therapy staff members visit the home, what types of falls risk reduction activities
do they carry out?
☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
4.14: Chemotherapy
Use Adapt
Relevant Standards: HR.01.05.03, HR.01.06.01, HR.01.07.01, EC.02.02.01, MM.01.01.03, Question Question
MM.07.01.03 As Is for Use
Accreditation Programs/Settings: AHC, CAH, HAP, OME
How do you safely handle high-alert and hazardous medications such as oral chemotherapy
☐ ☐
agents?
What part do you play in making sure chemotherapy is used safely in this organization? ☐ ☐
Who oversees the processes to ensure that there is consistency in meeting safe practice
☐ ☐
requirements with chemotherapy medications?
What is organization policy regarding the use of personal protective equipment (PPE) during
chemotherapy administration?
☐ ☐
What process do you follow to add a chemotherapy drug to the hospital formulary? ☐ ☐
Where are chemotherapy medications stored? How do you address safety issues associated with
storage of chemotherapy medications?
☐ ☐
How do you prepare chemotherapy medications? What steps do you take to ensure that
☐ ☐
preparation of chemotherapy drugs is done as safely as possible?
Pharmacist: What information do you need before preparing the chemotherapy infusion? ☐ ☐
Pharmacist: Does a second person check the concentration of chemotherapy preparations? If so,
☐ ☐
why?
How do you label the preparations when chemotherapy orders are filled? ☐ ☐
How do you determine and ensure required competencies for staff involved in chemotherapy
☐ ☐
preparation and dispensing?
How does chemotherapy medication get delivered to the unit and then to the patient? ☐ ☐
How are nurses who work in this area trained and deemed competent for the administration of
☐ ☐
chemotherapy medications? Please show documentation of this assessment.
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How much experience do you have in administering chemotherapy? How has this hospital helped
you enhance your competencies in administering chemotherapy?
☐ ☐
Patient: What does the nurse do to make sure that you are the correct patient before
☐ ☐
administering your chemotherapy?
What are your criteria for reporting adverse drug reactions involving chemotherapy agents? What
☐ ☐
is the follow-up process?
How do you track chemotherapy administration and monitor effects on the patient’s blood
☐ ☐
count?
What are the typical side effects one can expect with this type of chemotherapy? What are the
interventions that can help reduce these side effects? How were these interventions discussed ☐ ☐
with the patient and documented in the patient’s chart?
Patient: At the beginning of your treatments, what were you told about the risks and side effects,
☐ ☐
as well as the effectiveness, of receiving chemotherapy?
Patient: Have you had any side effects from the chemotherapy? If so, how have the nurses
☐ ☐
responded?
Patient: What did your caregivers say about chemotherapy safety issues? What information did
they provide regarding the handling of urine and waste?
☐ ☐
Patient: Please define what you think “neutropenic precautions” means. Why do your caregivers
take special precautions with your immune system?
☐ ☐
Patient: What behavioral changes have you made due to what you have learned about
☐ ☐
chemotherapy and your immune system? How have the precautions affected your visitors?
What training have you received relative to chemotherapy? What action would you take if a
☐ ☐
chemotherapy infusion spilled?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Do you have a policy on restraint and seclusion? May I see the policy? ☐ ☐
Please describe your assessment of a patient’s need for restraint and/or seclusion. ☐ ☐
What screening is used to decide on an immediate (emergency) use of restraint and/or seclusion? ☐ ☐
How does staff respond to a call for immediate (emergency) use of restraint and/or seclusion? ☐ ☐
When is restraint and/or seclusion discontinued? How is that decided and documented? ☐ ☐
Are the patient and family provided information on the use of restraint? ☐ ☐
How is the staff educated and trained in the appropriate and safe use of restraint and seclusion?
☐ ☐
Is de-escalation and management of challenging behaviors part of that training?
How are staff and providers evaluated on competencies related to the use of restraint and
☐ ☐
seclusion? May I see an example of documentation of that competency assessment?
How are adverse events as a result of restraint and/or seclusion reported and investigated? ☐ ☐
How does your organization prevent, reduce, and strive to eliminate restraint and seclusion?
☐ ☐
What resources are provided for performance improvement in this area?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
How do you receive new youths into the addiction program? What types of
screenings/assessments do you perform? Where is this documented? Who has access to this ☐ ☐
documentation?
What planning of care, treatment, or services do you perform for individuals served in a youth
addiction program? Describe your program’s process for creating a care, treatment, or services ☐ ☐
plan. How do you review and update the process, if needed? Who is involved?
How are youths and their parents involved in the assessment and planning of care, treatment, or
☐ ☐
services?
How do you document the plan for care, treatment, or services for individuals served in a youth
addiction program? How do you document the diagnosis by a qualified practitioner and any ☐ ☐
sessions with a youth or his or her parents?
How do you determine and proceed with a medically supervised detox for individuals served in a
☐ ☐
youth addiction program?
How do you ascertain specific needs, such as de-escalation methods for individuals served in a
youth addiction program?
☐ ☐
What happens in the event of an escalation? How is this documented? What safety measures do
☐ ☐
you have in place for staff and youths?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Does your organization honor advance directives? May I see the policy that explains this? ☐ ☐
What process does your organization use to resolve ethical issues that might arise related to
advance directives? Who is involved in that process? What happens if staff involved in that ☐ ☐
process are not able to come to agreement?
What is the process for making decisions about a patient’s condition if no family is available and
☐ ☐
the patient has not left advance directives?
How do you determine a patient’s or family’s preferences related to resuscitation and life-
☐ ☐
sustaining treatment?
How do you document preferences regarding resuscitation and life-sustaining treatment that
come from someone other than the patient or physician (for example, a family member or ☐ ☐
significant other)?
How is the interdisciplinary team for the patient’s plan of care informed about the patient’s and
☐ ☐
family’s wishes?
What mechanisms are in place to facilitate interdisciplinary team communication about advance
☐ ☐
directives?
Have there been any recent incidents related to advance directives? If so, please describe what
☐ ☐
happened. What changes are being implemented as a result of the incident?
What training have you provided staff on the processes used to address ethical issues related to
their job duties and responsibilities? Where is this training documented? How have you oriented ☐ ☐
staff on patients’ rights and preferences regarding life-sustaining treatment and resuscitation?
Does the organization have anyone to help staff in cases of ethical dilemmas? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Will you please show me some examples of patient education documented in the medical record? ☐ ☐
Patient: What instructions were you given regarding preparation for this treatment/procedure?
☐ ☐
Did you understand and follow the instructions?
Patient: What were you told about the forms that you signed? ☐ ☐
Patient: What tests did you undergo? Were you informed of the reasons and the results of each
☐ ☐
test?
Patient: Please tell me about your condition. What information have you received about your
☐ ☐
condition and the treatment you have been receiving?
Patient: What treatment are you currently undergoing? Have you been informed of any risks
☐ ☐
associated with that treatment?
Patient: Have you been educated about symptoms that indicate a worsening of your condition?
What should you do if that occurs?
☐ ☐
Patient: How will you manage your health when you return home? Do you feel prepared to do
☐ ☐
that?
Patient: What additional information, if any, do you need to make informed decisions about your
☐ ☐
care?
Family: Have you been educated about symptoms of your family member that you should report
☐ ☐
to the nurse?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
How do you verify that patients and family have understood the information you have provided?
☐ ☐
What type of follow-up do you provide to ensure understanding?
Patient: How well do you understand the care that you have been provided? What do you do if
you have a question about your care?
☐ ☐
How do you accommodate the cultural and linguistic needs of patients and families? ☐ ☐
How do you ensure that patients receive information in their preferred language? ☐ ☐
What processes have you put in place to address any linguistic or cultural differences between
☐ ☐
patients and staff?
Have you offered any additional skills training for staff with regard to cultural competency? If so,
☐ ☐
what improvements have you tracked or documented as a result of additional training?
How do you ascertain the role or presence of family or significant others for this patient? ☐ ☐
What is the process for communicating unexpected outcomes with patients and families? ☐ ☐
Patient: Do you understand why your stay in the facility has been prolonged? How was this
☐ ☐
information communicated to you?
Family: What instructions have you been given about bringing food and other items into the
patient’s room? Do you understand why there might be limitations in relation to such items?
☐ ☐
Is information provided to the patient and family given only verbally, or are printed materials
☐ ☐
provided as well?
Patient: Do you think this organization respects your rights as a patient? If not, why not? If so,
☐ ☐
how is that demonstrated?
Patient: Can you please tell me how you were informed of your rights as a patient? ☐ ☐
Patient: What do you know about your rights as a patient? For example, do you know about your
right to participate in decisions about your care, treatment, and services? To give or withhold ☐ ☐
consent? To be free from abuse, neglect, and exploitation?
How do you confirm that patients have received information about their rights and
☐ ☐
responsibilities? Where is that documented?
Patient: Can you please tell me how you were informed of your responsibilities as a patient? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
Patient: How have you been informed of the organization’s expectations for your financial
☐ ☐
obligations for your care, treatment, and services?
How do you handle patients who do not show respect or consideration for staff and other
☐ ☐
patients?
How do you reiterate to patients the potential for undesirable outcomes if they do not follow
their plan of care, treatment, and services? How do you encourage patients to accept ☐ ☐
responsibility for outcomes if they do not follow their plan of care, treatment, and services?
Patient and Family: How has your experience of care been here? Have you had your care needs
met? Have there been any concerns? If so, how have you communicated them?
☐ ☐
Patient: Have you felt well informed throughout your care experience? If not, how could that be
☐ ☐
improved, in your opinion?
Patient and Family: What have you done if you have had questions? How do you get responses to
☐ ☐
your questions?
Patient: How did staff members encourage you to ask questions about your treatment? What do
you think of the answers they gave you?
☐ ☐
Patient and Family: Do you know how to file a complaint about safety or care concerns in the
☐ ☐
organization?
* Tracer questions about education and communication related to specific areas of patient care, treatment, or services are
included in tracer question sets on those topic areas.
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
Who has responsibility and oversight for data management and use in your organization? ☐ ☐
What kind of training and education are provided for data users and data management staff? ☐ ☐
How do you ensure that all data is collected as planned? How is data received from external
☐ ☐
sources?
Are your data management processes responsive to organizational changes, including expansion? ☐ ☐
If you are using data software, what is your contingency plan if there is a problem with the
☐ ☐
software?
How do you determine the most appropriate data software and training for your organization? ☐ ☐
How do you manage quality control records for the software (document, report, store, back up)? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
May I see your written policies that address health information privacy and security? ☐ ☐
How do you manage risk of breaches in health information privacy and security? ☐ ☐
Is there a defined process for responding to theft of health information? ☐ ☐
Do you have a plan for recovery from accidental loss of health information? ☐ ☐
Do
you
have
an
emergency
response
plan
for
damages
to
health
information
(from
fire,
vandalism,
system
failure,
natural
disasters,
and
so
on)?
☐
☐
How
do
you
limit
the
use
and
disclosure
of
health
information?
How
do
you
monitor
unauthorized
access
of
health
information?
☐
☐
What
is
your
process
for
setting
up
and
removing
rights
to
access,
use,
and
disclose
health
information?
☐
☐
May I see the secure medical records room? [N/A for LAB or OME] ☐ ☐
Who
gets
training
on
sharing
information
in
a
medical
record?
Do
you
require
annual
HIPAA
training
for
all
employees?
☐
☐
How do you maintain the patient’s health information privacy during registration? [N/A for OME] ☐ ☐
How
do
you
deal
with
requests
from
the
patient
or
family
for
information
in
the
patient’s
medical
record?
[N/A
for
LAB]
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
What forms or education about informed consent do you share with patients? ☐ ☐
During the informed consent process, how do you discuss with patients their treatments and
procedures, including risks, benefits, and alternatives? Which staff are involved in these ☐ ☐
conversations, and who answers questions from the patient or family?
Do you provide informed consent explanations verbally only, or do you also provide printed
☐ ☐
information?
What are your organization’s policies and procedures regarding interpreters for the informed
☐ ☐
consent process?
Are your informed consent forms in English only? If so, how do you obtain informed consent from
patients with limited English proficiency? How do you determine if they have limited English ☐ ☐
proficiency?
How is patient education during the informed consent process documented in the patient record? ☐ ☐
Please provide the consent forms for the patient, including any for medications as well as imaging
☐ ☐
or surgical procedures.
To Patient: Did you sign a consent form? Who was present when you signed it? When was that
☐ ☐
done?
To Patient: What is your understanding of the informed consent process and form? Who
explained the treatment or procedure to you? Did the explanation include the risks and benefits ☐ ☐
as well as alternatives?
To Surgical Staff: What is your process for making sure that the informed consent was properly
☐ ☐
obtained? [CAH, HAP, and OBS only]
To Surgical Staff: Do you use a preoperative checklist? Does it include documentation about the
☐ ☐
patient’s informed consent? [CAH, HAP, and OBS only]
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Is the medical record completely electronic or is it a hybrid of electronic and paper? If the medical
record is still partially paper, when are those documents scanned into the electronic record? Who ☐ ☐
is responsible for doing that?
What do you document in the patient’s medical record? What is your organization’s policy on
☐ ☐
what is included in the record?
Are prohibited abbreviations and dose designations (as defined by policy) absent from the
☐ ☐
medical record?
What training have you had regarding the use of unapproved abbreviations? ☐ ☐
Does the medical record contain the patient’s race and ethnicity? ☐ ☐
How do you document the care, treatment, and services you are providing to the patient? ☐ ☐
How is information in the medical record communicated to relevant staff for care planning
☐ ☐
purposes?
Is it clear in the medical record who made each entry? Are the entries timed and dated? ☐ ☐
Where in the medical record do you document education you provided the patient? ☐ ☐
When it is necessary to call the prescribing physician or other provider for new orders, how do
☐ ☐
you document it?
Please show me the clinical record of an individual receiving medication. Where do you document
☐ ☐
treatment and care planning related to medication?
How are the side effects and responses to medications taken (for example, weight gain, metabolic
☐ ☐
syndrome, and so on) documented and used?
If a patient has an adverse reaction to an injection, how is that noted in the medical record? ☐ ☐
Where in the patient’s medical record do you record the prescribed wound care orders and
☐ ☐
current medication list?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How do you receive and implement orders from the surgeon and the anesthesiologist? How are
those orders documented? [CAH, HAP, and OBS only]
☐ ☐
If an operative or other high-risk procedure was performed, was the complete report written or
dictated in the time frame defined by your policy? If not, was an immediate progress note ☐ ☐
written?
Does the operative or other high-risk procedure report or progress note in the medical record
include this information? [N/A for BHC, NCC, or OME]
• Name(s) of practitioner(s) performing the procedure and any assistants
• Procedure(s) performed
• Description(s) of the procedure(s) ☐ ☐
• Findings of the procedure(s)
• Any estimated blood loss
• Any specimen(s) removed
• Postoperative diagnosis
For planned recurring outpatient visits, was a summary list* started for the patient by the third
☐ ☐
visit? [N/A for BHC, NCC, OBS, or OME]
Does the patient’s summary list* contain this information? [N/A for BHC, NCC, OBS, or OME]
• Any significant medical diagnoses and conditions
• Any significant operative and invasive procedures ☐ ☐
• Any adverse and allergic drug reactions
• Any current medications, over-the counter medications, and herbal preparations
Is the patient’s summary list* updated whenever there’s a change in diagnoses, medications and
allergies to medications, and whenever a procedure is performed? [N/A for BHC, NCC, OBS, or ☐ ☐
OME]
Can practitioners access the summary list* information quickly and easily? [N/A for BHC, NCC,
☐ ☐
OBS, or OME]
Did you provide written discharge instructions* in a way that allowed the patient and/or the
☐ ☐
patient’s family, significant other, or caregiver to understand them?
Does the medical record contain a concise discharge summary* that includes this information?
• Reason for the inpatient stay
• Care, treatment, and services provided, including any procedures ☐ ☐
• Patient’s condition and disposition at discharge
• Information provided to the patient, family, and significant others
• Provisions for follow-up care
How
do
orders
come
into
your
organization?
Is
there
any
variation
among
departments/units/locations?
☐
☐
How
do
you
manage
orders
given
verbally,
including
those
by
telephone?
Is
record
and
read
back
part
of
your
process?
☐
☐
Are
all
verbal
orders
taken
by
a
practitioner
who
is
authorized
to
receive
and
record
such
orders,
per
your
policy?
☐
☐
If an order was given verbally, was it authenticated within the time frame defined by policy? ☐ ☐
Does
the
authentication
include
the
signature
of
the
practitioner
and
the
date
and
time
of
the
order?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Who is responsible for infection prevention and control in your organization? What training and
☐ ☐
education do these leaders receive on infection prevention and control?
What oversight do you have in place to manage your infection prevention and control activities? ☐ ☐
If you have an infection prevention and control committee, how does that committee function? ☐ ☐
How often does your committee meet? What kind of representation is on it? ☐ ☐
What disciplines or departments are represented on the infection prevention and control
committee? Why? How are they educated to the requirements of infection prevention and ☐ ☐
control?
Is infection prevention and control represented in other forums in the organization (such as
☐ ☐
environmental, pharmacy, or performance improvement committees)?
How do you prepare for and make modifications to existing or new policies? How are these
☐ ☐
implemented?
Can you describe your infection prevention and control processes in the organization? ☐ ☐
What processes do you have in place to review the effectiveness of your existing infection
☐ ☐
prevention and control processes and systems?
How do you train staff on infection prevention and control processes? Who is responsible for the
☐ ☐
training? How is this documented?
How do you ensure that staff understand and follow procedures related to infection prevention
☐ ☐
and control?
What infection prevention and control competency activities do you provide to staff? How is this
documented and tracked? How about infection prevention and control orientation for new staff?
☐ ☐
Are infection prevention and control concerns integrated into your information management
☐ ☐
planning?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
What types of infection prevention education are provided to patients? What is required by the
☐ ☐
state, in terms of infection prevention education? [N/A for LAB]
Do you document patient education on infection prevention and control? If so, where and how is
☐ ☐
it documented? [N/A for LAB]
How are patients and families educated on informing you about any infection prevention and
☐ ☐
control concerns they may have, such as signs of an infection? [N/A for LAB]
How do you accommodate the cultural and linguistic needs of patients and families in the
☐ ☐
education you provide on infection prevention and control? [N/A for LAB]
What specific infection prevention and control issues do you need to consider in your setting? ☐ ☐
What infection prevention and control risk assessments have you performed? When and where?
☐ ☐
Can you show me the documentation?
How are infection prevention and control risks monitored? How is this communicated to staff? ☐ ☐
How do you prioritize infection prevention and control risks to plan for? How is this documented? ☐ ☐
How does the staff research the infectious disease risks for the population it serves? ☐ ☐
What additional resources do you use to identify prevalent infection risks in your population? ☐ ☐
How does the staff research the possible infection risks due to common behaviors in your
population (drug use, sexual activity, etc.)?
☐ ☐
How has the literature regarding infectious risk in your population base been considered? What
about special populations among your patients?
☐ ☐
Were any other characteristics of your population considered in the design of your infection
☐ ☐
prevention and control program or education activities?
In instances in which you have identified an infection prevention and control risk, what was your
☐ ☐
performance improvement plan? How were staff informed about the plan?
How do you select preventive infection control activities? Do you address all the National Patient
☐ ☐
Safety Goals related to infection prevention and control?
How did you roll out the infection prevention and control performance improvement plan
☐ ☐
throughout the organization? How are you monitoring progress?
What kinds of improvement initiatives is your infection prevention and control committee
currently implementing? How did you select these initiatives? How did you prioritize these ☐ ☐
initiatives? What types of activities are involved in each?
How have you educated and trained staff on these improvement initiatives? How are you ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
monitoring progress? How are you reinforcing the project in an ongoing manner?
What is your planned response to a potential influx of infectious patients? [N/A for LAB] ☐ ☐
Have you conducted any drills around a potential influx of infectious patients? How have you
engaged staff in the process? Have you analyzed the effectiveness of response to these drills? ☐ ☐
Have you made improvements based on this analysis? [N/A for LAB]
Describe a recent outbreak and what your staff did to bring it under control. What was the source
of the outbreak? How many people were affected by the outbreak? How did you determine when ☐ ☐
the outbreak had been contained? [N/A for LAB]
What types of care related to infection control are provided for any therapeutic animals in your
facility? What happens if one of those animals becomes ill? Please provide copies of the animals’ ☐ ☐
health records. [BHC only]
What are the organization’s policies on infectious waste disposal? Who develops these policies?
☐ ☐
How often are these policies reviewed?
What training does the organization provide to staff on infectious waste policies? ☐ ☐
What infection control precautions should be taken for a child suspected of having pertussis?
Please provide a copy of the policy and procedures for pertussis infection control. [N/A for BHC ☐ ☐
and LAB]
Does the organization have an antimicrobial stewardship program? If not, how do you ensure that
antimicrobial agents are used properly? If so, what are the antimicrobial stewardship activities? ☐ ☐
Describe the process and its outcomes.
What training have you received that qualifies you to serve on the antimicrobial
stewardship team?
☐ ☐
Does the antimicrobial stewardship team track the use of vancomycin? How does it use that
information?
☐ ☐
How often do you tour your physical environment for infection control–related issues? ☐ ☐
Are you involved in the selection of products for infection prevention equipment, devices, or
supplies?
☐ ☐
What is the infection prevention leader’s role in the risk management related to construction,
☐ ☐
demolition, and remodeling projects?
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
What guidelines does the organization follow for infection prevention and hand hygiene? ☐ ☐
Please provide a copy of your organization’s hand hygiene policy and infection control plan. ☐ ☐
What are your goals for improving hand hygiene? How are you implementing those goals? ☐ ☐
What training and orientation have you received regarding hand hygiene? Can you tell me what is
☐ ☐
required?
When you conducted your baseline assessment of hand hygiene compliance, what did you review
☐ ☐
or assess? How did you use the results to make conclusions?
What types of risk assessments are you performing to identify risks from health care–associated
☐ ☐
infections (HAIs) due to multidrug-resistant organism (MDROs)? [CAH and HAP only]
Please describe the evidence-based practices you use to control HAI risks from MDROs. [CAH and
HAP only]
☐ ☐
How do you educate and train staff about prevention of central line–associated bloodstream
infections (CLABSIs) [CAH, HAP, and NCC only]
☐ ☐
How do you educate and train patients and their families about prevention of central line–
associated bloodstream infections (CLABSIs) [CAH and HAP only]
☐ ☐
What evidence-based practices have you implemented to reduce surgical site infections? [AHC,
CAH, HAP, and OBS only]
☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What kind of staff education and training do you provide regarding preventing surgical site
infections? How are physicians and other providers educated and involved in the process? [AHC, ☐ ☐
CAH, HAP, and OBS only]
Please show me where in your policies you address reducing the risk of surgical site infections.
☐ ☐
[AHC, CAH, HAP, and OBS only]
With relation to any improvement efforts to prevent catheter-associated urinary tract infections
☐ ☐
(CAUTIs), what kind of staff education and training do you provide? [CAH, HAP, and NCC only]
Describe the processes for catheter-associated urinary tract infection (CAUTI) prevention, and
☐ ☐
provide a written copy of those processes. [CAH, HAP, and NCC only]
In what ways do you use evidence-based guidelines to prevent catheter-associated urinary tract
☐ ☐
infections (CAUTIs)? [CAH, HAP, and NCC only]
How do you educate patients and their families about preventing catheter-associated urinary
☐ ☐
tract infections (CAUTIs)? [CAH, HAP, and NCC only]
How do you measure and monitor improvement efforts designed to prevent catheter-associated
☐ ☐
urinary tract infections (CAUTIs)? [CAH, HAP, and NCC only]
What is the CAUTI rate for your particular unit? [CAH, HAP, and NCC only] ☐ ☐
When was the last CAUTI-reduction initiative? [CAH, HAP, and NCC only] ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Please describe your reprocessing activities from point-of-use in the procedure room to
☐ ☐
decontamination, high-level disinfection/sterilization, and then to storage.
What is involved in your risk assessment for reprocessing? Is risk assessment conducted in all
☐ ☐
locations that conduct high-level disinfection and sterilization?
How do you assess competency in following reprocessing policy and procedure, including
competency of frontline staff that conduct high-level disinfection and sterilization? How do you ☐ ☐
assess competency of those with managerial/supervisory oversight that sign off on competencies?
How often are staff given refresher training on reprocessing? What does the training include? ☐ ☐
How does your training differ for items labeled as single-use disposable versus items that may be
☐ ☐
reprocessed for repeated use?
Describe your process of cleaning medical equipment, devices, and supplies before any further
☐ ☐
disinfection or sterilization.
How do you ensure that cleaning and disinfection are performed in a consistent and effective
☐ ☐
manner?
How do you ensure that manufacturer’s guidelines for the type of high-level disinfectant solutions
☐ ☐
used are available to staff?
What is the testing efficacy of disinfectant solutions? When are the solutions changed? ☐ ☐
How often do you clean the toys and furniture in the waiting room? How is this cleaning
documented? What products are used for disinfection in general and when a patient has been ☐ ☐
identified as posing a high risk of infection?
How do you ensure that manufacturer’s instructions are followed for automated endoscope
☐ ☐
reprocessers? [N/A for BHC]
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What would happen if a scope were dropped during use or reprocessing? [N/A for BHC] ☐ ☐
Please describe your process for storing clean scopes. [N/A for BHC] ☐ ☐
What information regarding reprocessing services is reported to your facility’s infection control
☐ ☐
committee?
What are your quality monitoring parameters for sterilization? How are physical, chemical, and
biological indicators performed and documented? Is this done per evidence-based guidelines and ☐ ☐
manufacturer’s instructions for use?
What are your quality monitoring parameters for high-level disinfection, such as the correct use of
test strips, monitoring the temperature and time of the disinfection, and so on? How do you ☐ ☐
ensure procedures are following manufacturer’s instructions for use?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Do you have an annual influenza vaccination program that is offered to licensed independent
☐ ☐
practitioners and staff? How do you communicate information about the program?
Does the organization provide influenza vaccination at sites accessible to licensed independent
☐ ☐
practitioners and staff?
Does the organization include in its infection control plan the goal of improving influenza
☐ ☐
vaccination rates?
Does the organization set incremental influenza vaccination goals, consistent with achieving the
☐ ☐
rate established by the US Department of Health and Human Services?
Does the organization evaluate the reasons given by staff and licensed independent practitioners
for declining the influenza vaccination? Does this evaluation occur at least annually? Explain how ☐ ☐
the evaluation is performed. What changes have been made as a result of the data?
How do you ensure that your staff’s immunizations are up to date? How do leaders, coworkers,
☐ ☐
and patients know which employees have received the influenza vaccination for the current year?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Who
is
responsible
for
monitoring
medication
management?
Who
has
overall
oversight
for
the
system?
What
is
the
reporting
process?
What
is
the
frequency
of
reporting?
☐
☐
Tell
me
about
your
medication
management
system.
How
did
you
design
it
and
who
was
involved?
☐
☐
What
is
your
background
related
to
medication
management?
What
type
of
training
related
to
medication
management
have
you
had?
☐
☐
What
ongoing
training
in
medication
management
do
you
receive?
What
type
of
training
resources
are
available
to
you?
☐
☐
How
is
pharmacy
staff
involved
in
the
development
of
medication
management
policies?
How
is
pharmacy
staff
involved
in
training
of
staff
involved
in
medication
system
processes?
☐
☐
How do you evaluate your medication management system? How often do you do this? ☐ ☐
What
is
your
process
to
make
modifications
to
the
system,
if
appropriate
or
warranted?
How
is
this
documented?
☐
☐
What performance improvement activities related to medication management are in place? ☐ ☐
What
evidence
based
guidelines
or
best
practices
inform
changes
and
improvements
to
your
medication
management
system?
☐
☐
What data do you collect relating to medication management? How do you use that data? ☐ ☐
What
process
do
you
have
to
collect,
aggregate,
analyze,
and
track
data
relating
to
medication
management?
☐
☐
How
do
you
analyze
the
data
to
identify
trends
and
opportunities
for
improvement?
☐
☐
©
2017
The
Joint
Commission.
May
be
adapted
for
internal
use.
Page
1
of
4
Please
describe
the
nature
of
analysis
of
any
recent
medication
management
issues.
What
tool
do
you
use
to
analyze
medication
management
issues
and
process
them
for
reporting?
☐
☐
What
type
of
medication
management
interventions
have
you
implemented?
How
are
you
tracking
results?
☐
☐
Describe
the
medication
management
system
for
the
inpatient
behavioral
health
units.
[CAH
and
HAP
only]
☐
☐
How
do
pharmacists
and
physicians
interact
to
improve
medication
management
processes
in
behavioral
health
units?
[CAH
and
HAP
only]
☐
☐
What
types
of
data
are
collected
to
document
the
problems
and
to
guide
improvements
to
the
medication
management
processes
in
behavioral
health
units?
[CAH
and
HAP
only]
☐
☐
Have
any
improvements
been
made
to
the
medication
management
system
in
behavioral
health
units
in
the
past
year?
How
are
these
improvements
sustained?
[CAH
and
HAP
only]
☐
☐
How
do
pharmacists
and
anesthesia
providers
interact
to
improve
medication
management
processes?
[CAH
and
HAP
only]
☐
☐
What
types
of
data
are
collected
to
document
the
problems
and
to
guide
improvements
to
the
medication
management
processes
in
the
operating
room
(or
perioperative
services)?
[CAH
and
☐
☐
HAP
only]
Explain the protocols you use to prescribe multiple psychotropic medications. ☐ ☐
What is the medication management process for an opioid treatment program? [BHC only] ☐ ☐
How
do
you
educate
staff
and
licensed
independent
practitioners
(LIPs)
on
the
medication
management
system?
What
do
you
do
to
orient
new
staff
and
LIPs?
How
are
they
educated
or
☐
☐
updated
on
changes
to
processes
in
the
system?
How
is
this
documented?
What
patient
education
do
you
provide
related
to
the
medication
management
system?
What
specific
information
do
you
provide
in
certain
cases,
such
as
vaccinations
for
pediatric
patients?
☐
☐
How
do
you
document
processes
in
the
medication
management
system,
such
as
administration
and
monitoring?
☐
☐
How
do
you
stay
apprised
of
any
new
or
developing
medication
safety
issues?
How
is
this
information
reported
to
staff
and
licensed
independent
practitioners?
☐
☐
Provide
an
example
of
an
everyday
medication
safety
step
you
perform
that
explicitly
adheres
to
your
organization’s
medication
safety
policy.
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 4
What process or method do you use to track medications from procurement through monitoring? ☐ ☐
How
do
you
plan
for
specific
medication
issues,
such
as
recalls
and
shortages,
and
having
an
accurate
and
current
list
of
medications?
☐
☐
What
are
the
high-‐risk
areas
you
have
identified
in
your
medication
management
system
processes?
How
have
you
identified
them?
☐
☐
What
improvements
have
been
made
to
the
medication
management
system
for
high-‐alert
medications?
How
are
these
improvements
sustained?
How
do
you
know?
☐
☐
What
processes
does
the
team
use
to
manage
the
patient’s
medications?
Does
your
organization
use
any
analgesic
or
medication
management
algorithm
as
part
of
your
care
planning?
☐
☐
Explain
the
process
used
to
obtain
accurate
and
complete
medication
histories
from
patients.
How
do
you
know
that
this
process
is
being
carried
out?
☐
☐
What is the process for developing a list of discharge medications? ☐ ☐
Are patients encouraged to maintain a medication profile and to bring it to each visit? ☐ ☐
How
are
medication
errors
reported?
What
procedure
does
the
organization
follow
if
an
error
is
caught
before
it
reaches
the
patient?
Have
you
ever
reported
an
error
or
a
near
miss?
☐
☐
What kinds of adverse events or close calls related to medications do you track? ☐ ☐
Have
you
ever
been
involved
in
a
situation
where
there
was
a
close
call
or
adverse
event
related
to
medications?
What
was
your
response?
☐
☐
What
policies
have
been
implemented
specifically
to
control
unwanted
issues
surrounding
“problematic”
medications,
such
as
insulin?
☐
☐
Do
you
believe
that
the
data
you’ve
collected
so
far
on
medication
errors
are
accurate
and
useful?
Why
or
why
not?
☐
☐
What does the data analysis show about the possible causes of medication errors? ☐ ☐
What
medication
management
work-‐arounds
are
you
aware
of
in
your
units
that
could
be
considered
security
risk
points?
☐
☐
What
training
has
been
provided
to
the
nursing
staff/licensed
independent
practitioners
regarding
high
medication
error
rates
related
to
overrides?
☐
☐
What
education
do
patients
receive
when
being
provided
with
sample
medications?
Are
written
instructions
provided?
☐
☐
What
issues
have
been
identified
regarding
control,
labeling,
security,
and
documentation
of
sample
medications?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 4
Has
patient
access
to
sample
medications
been
identified
as
a
safety
risk,
and
if
so,
what
has
been
done
to
minimize
this
risk?
☐
☐
What
improvements
have
been
implemented
to
correct
any
problems
related
to
management
of
sample
medications?
☐
☐
Does
each
patient
and/or
family
receive
a
complete
list
of
medications
at
discharge
(or
at
the
end
of
an
episode
of
care)?
How
is
this
process
documented?
☐
☐
When
patients
return
to
refill
medications,
how
do
you
check
with
them
to
find
out
if
they
are
complying
with
instructions?
☐
☐
Are
processes
related
to
comfort
kits
part
of
the
evaluation
of
the
medication
management
system?
[OME
Hospice
only]
☐
☐
How
does
the
organization
assess
whether
comfort
kits
are
safe
in
the
patient’s
home?
[OME
Hospice
only]
☐
☐
What are the policy and processes for the use of comfort kits? [OME Hospice only] ☐ ☐
How
are
staff
made
aware
of
DEA
and
state
regulations
for
the
use
of
comfort
kits?
[OME
Hospice
only]
☐
☐
Describe what you know about the ordering and creation of comfort kits. [OME Hospice only] ☐ ☐
How
is
patient
compliance
with
the
use
of
the
medications
in
the
kits
evaluated?
[OME
Hospice
only]
☐
☐
How are patients/caregivers educated on each medication in the kit? [OME Hospice only] ☐ ☐
How
is
the
patient's/caregiver's
retention
of
the
educational
activities
in
the
comfort
kit
evaluated?
[OME
Hospice
only]
☐
☐
How is the effectiveness of the kit’s medications monitored? [OME Hospice only] ☐ ☐
What is done if a patient dies and the comfort kit has not been used? [OME Hospice only] ☐ ☐
What
procedures
are
used
to
ensure
that
the
comfort
kits
are
compliant
with
DEA
and
state
regulations
and
organization
policy?
[OME
Hospice
only]
☐
☐
What policies or protocol does your organization have on antimicrobial stewardship? ☐ ☐
What data is your organization collecting and analyzing regarding antimicrobial stewardship? ☐ ☐
How do you procure and receive medications in the facility? Who is responsible for this? How are
☐ ☐
these processes reviewed?
Is there a pediatric formulary? If so, are prescribers and nurses aware of the medications on this
☐ ☐
list? What emergency medications do you have specifically for the pediatric population?
In relation to medication management, do you have any special medications you need to have on
☐ ☐
hand?
How are medications prescribed? What policies are in place related to prescribing? [N/A for OBS] ☐ ☐
How are medications prescribed for your current patients? [N/A for OBS] ☐ ☐
What is the prescription process for medications that have doses based on weight of the patient?
[N/A for OBS]
☐ ☐
Discuss the process of ordering the medications your patients currently receive. [N/A for OBS] ☐ ☐
What is the protocol for changing an individual’s medication? How changes to medication are
communicated to other staff members? [N/A for OBS]
☐ ☐
What types of medications are most often prescribed in the nursing units? Name about 10 of
☐ ☐
them. Which on this list are considered by the organization to be “problematic”? [N/A for OBS]
Does your organization use “signed and held” medication orders? If so how are these medication
orders implemented?
☐ ☐
Please describe your organization’s approach for medication range orders. Do you allow range
☐ ☐
orders and if so, under what circumstances?
Have you considered developing a formal list of medications associated with falls, like blood
pressure medications, sedating medications, diuretics, and analgesics—opiates and muscle ☐ ☐
relaxants in particular? [N/A for OBS]
As part of your falls assessment process, do you review medication profiles for medications that
☐ ☐
have the potential to cause falls? [N/A for OBS]
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
How are medication orders reviewed for accuracy? What are the elements of a complete order?
Do you have a written policy defining this? [N/A for OBS]
☐ ☐
How are medication orders reviewed for appropriateness? What are the elements of the review?
☐ ☐
[N/A for OBS]
What are your systems for quality control when medication orders are filled? ☐ ☐
Has your pharmacy provided training regarding the error-reduction potential of a pharmacist
☐ ☐
review of medication orders?
What processes are in place to validate allergy information for medications that have an increased
☐ ☐
potential for producing adverse drug events? [N/A for OBS]
Does the pharmacy communicate with each patient to verify his or her allergy status? [N/A for
☐ ☐
OBS]
Can you tell me about an instance in which there was an adverse reaction to a medication? Were
processes for validating allergy information and analyzing adverse drug events followed in this ☐ ☐
instance? [N/A for OBS]
What is the process for ordering narcotics? What is the process to enter the narcotics into the
main inventory after the narcotics package has arrived at the organization?
☐ ☐
What is the process for anesthesia providers to obtain narcotics/controlled substances? If the
anesthesia provider or nurse (in the case of moderate sedation) obtains controlled substances for ☐ ☐
more than one patient, what is the reconciliation process? [AHC, CAH, HAP, and OBS only]
What do you do if you do not receive a needed medication from the pharmacy? ☐ ☐
What is the controlled substances counting process? What drugs are considered controlled
☐ ☐
substances at your organization?
Do you contract with a pharmacy or pharmacist for oversight? If so, how do you communicate and
interact with that pharmacy/pharmacist? What are the pharmacist responsibilities? How often is ☐ ☐
the contract reviewed? How is that review documented?
Does the pharmacist generate a report after reviewing the medication management process?
How many charts does the pharmacist audit for diversion? Does the pharmacist audit sedation
charts for diversion? May I see the data? What is the process for the information from the
☐ ☐
reports to be evaluated by the governing body?
May I see the infusion bag label for the medication that was just compounded? ☐ ☐
Please explain the type of environmental control unit or device that you use when compounding
☐ ☐
sterile medications.
How do you evaluate the competency of your sterile compounding staff? How often is this done? ☐ ☐
How often do you perform environmental sampling of your sterile compounding facilities and
☐ ☐
equipment? Please provide me with the documentation of the testing for the past year.
What medications are parts of floor stock? If you need to prepare a dose of medication, what is
☐ ☐
the process for doing so? Where is the medication prepared?
How are medications provided for pediatric patients? Who prepares them? ☐ ☐
Does the pharmacy have the capability to prepare medication like epinephrine in the appropriate
☐ ☐
dosage forms if not available from the manufacturer?
What is your process for labeling prepared medications? What if the medication is not going to be
immediately administered?
☐ ☐
Does the pharmacy make special provisions for high-risk patients in its on-call process? ☐ ☐
When the pharmacy is closed, what are your processes for making sure that a new medication
☐ ☐
order is properly reviewed prior to administration?
Under what circumstances would a nurse need to call a pharmacist after hours? ☐ ☐
Are nursing and licensed independent practitioners aware of the on-call policies for the
☐ ☐
pharmacy?
What are your organization’s policies and procedures on use of an automatic dispensing cabinet?
☐ ☐
[N/A for OBS]
Are there specific or unique steps to follow in withdrawing heparin or other high-alert
☐ ☐
medications from an automatic dispensing cabinet? [N/A for OBS]
Describe in detail the steps you take in restocking the automatic dispensing cabinet. [N/A for OBS] ☐ ☐
Describe the entire process you use from receipt of heparin orders through stocking the
☐ ☐
automatic dispensing cabinet. [N/A for OBS]
Does your organization have a policy on the types of medication overrides that will be reviewed
for appropriateness and the frequency of the reviews when automatic dispensing cabinets are ☐ ☐
used?
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
Please describe the process of distributing medications and your exact role in it. ☐ ☐
How do you work with the pharmacy and the physician or licensed independent practitioner
☐ ☐
when questions or concerns arise about administering medications?
Have medication error data collected been used to improve the medication administration
process? How are the data analyzed and reported? What interventions have been implemented in ☐ ☐
response to the data?
How do you verify that the correct medications are being administered to the correct patient at
☐ ☐
the proper time, in the prescribed does, and by the correct route?
Do you review the medication label to see whether it includes the required information? ☐ ☐
What are you checking for on the labels of medications before you administer them? ☐ ☐
How do you check for contraindications on medications you administer? [N/A for BHC] ☐ ☐
What are you looking for when you visually inspect medications? ☐ ☐
May I observe as you follow procedure to assess the patient prior to administering medication? ☐ ☐
What are the elements of your checking process when it comes to correct admixtures? ☐ ☐
How does the bar-code process work? How do you use it for stat medications or for partial doses ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 4
Are medication bar-code bypasses tracked? Please explain how. How are bypasses analyzed? ☐ ☐
What other safety checks are in place beyond the bar-code system? ☐ ☐
How are doses adjusted? Who adjusts doses? Are they adjusted according to protocol? ☐ ☐
How do you check dosing on doses for medications that need to be weight based? ☐ ☐
Do you use the same standardized approach (pounds or kilograms) for all patients in determining
☐ ☐
the weight scheduling of their medication? How often is each patient’s weight record updated?
Provide details regarding your approach to adjusting doses according to the responses of critically
☐ ☐
ill patients.
How are titrated doses calculated? Show me how you would calculate a dose for this patient. ☐ ☐
What processes are involved in administering radioactive pharmaceuticals used for diagnostic
☐ ☐
purposes? [AHC, CAH, HAP only]
For radioactive pharmaceuticals used for diagnostic purposes, what else do you do before
☐ ☐
administering the drug? [AHC, CAH, HAP only]
How do you record and monitor opioid administration in this program? [BHC opioid treatment
☐ ☐
programs only]
What processes do you put in place to monitor medication administration and usage for
☐ ☐
psychiatric patients, particularly when monitoring for suicide risk?
In what locations do you administer vaccinations? Do you need a physician order to administer
☐ ☐
vaccinations? How is this order obtained?
Please show me any used vials and diluents for medications administered to this patient today. ☐ ☐
How are medication containers labeled when medications are prepared but not immediately
☐ ☐
administered? How are they labeled when the medications are prepared on the sterile field?
How can you tell if a medication is for single use or multidose use? ☐ ☐
What is the organization’s policy regarding the expiration dating of opened vials? ☐ ☐
Are opened multidose vials without new beyond-use dates (BUDs) routinely available for use on
patients?
☐ ☐
What is the correct beyond-use date (BUD) for opened multidose vials? ☐ ☐
What is the policy regarding the opening and storing of vials of medication without beyond-use
dates (BUDs)? Are multidose vials used for more than one patient when accessed in a patient care ☐ ☐
area, such as at the patient bedside?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 4
Please show me how you prepare a PICC line for medication administration. [CAH and HAP only] ☐ ☐
May I see the competency reviews for the pharmacy technician and/or the nurse? ☐ ☐
Are there special requirements for infusing heparin? Explain the steps in the administration
☐ ☐
process. [N/A for BHC or OME]
How are new staff members educated on the standard protocol for warfarin dosing? How is
☐ ☐
compliance monitored? [N/A for BHC]
Please describe the kind of equipment you use for administering anticoagulants and how you
monitor it. What safety measures are in place to ensure safe administration and dosing? How do ☐ ☐
you ensure that the INR and PTT results are accurate? [N/A for BHC]
If you use equipment, such as an infusion pump, how do you maintain the equipment? What do
☐ ☐
you do in the event of a problem with the equipment? [N/A for BHC]
How do you determine that a patient is safely able to tolerate the infusion? [N/A for BHC] ☐ ☐
How do you ensure that you are administering the infusion at the correct rate? [N/A for BHC] ☐ ☐
What is the process for administration of a dose using a smart pump? Please show me how you
☐ ☐
set up a smart pump. Do you take any special precautions? [N/A for BHC]
Do you ever make infusions in the ICU? What about emergent first doses? Where are these
☐ ☐
prepared? How do you know what concentrations to prepare? [CAH and HAP only]
Please describe the spinal or epidural process. What is the prep process for the lower spinal area?
What is the process for ensuring that correct medications are being used for the spinal or ☐ ☐
epidural? [CAH and HAP only]
Do the nurses change out the cartridges for labor epidural infusions? Who begins the infusion for
the parturient’s labor epidural infusions? How are the orders checked for accuracy? Do the ☐ ☐
nurses administer epidural medication boluses?
What are the policies and training for epidurals? What safety protocols are in place? What is the
☐ ☐
training for these activities?
Describe the policies and procedures that guide the self-administration of medications. [N/A for
AHC and OBS]
☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 4
How are reactions to medications monitored? As standard practice, do you tell patients what side
☐ ☐
effects to watch for?
What policies and procedures exist for monitoring of the effects of medications on patients? ☐ ☐
How do you monitor a patient for effects of the medications administered during transport? [CAH
☐ ☐
and HAP only]
Are you certified in advanced cardiac life support? If you are certified, what medications may you
☐ ☐
administer without a physician’s order? [CAH and HAP only]
Please explain how you mix and administer an IV for a cardiac patient. [CAH and HAP only] ☐ ☐
What special training do you have to qualify you to administer sedation to patients? How often is
competency evaluated? What methods are used to evaluate competency?
☐ ☐
What special training do you have to qualify you to administer sedation to patients? ☐ ☐
What is the organization’s policy for emergency medication dosage forms (for example, single
☐ ☐
use, pediatric dose, vials, syringes)?
What are the acquisition methods for obtaining emergency medication dosage in the appropriate
☐ ☐
form in the event of a shortage?
What is the organization's policy regarding the provision of emergency medications in their most
☐ ☐
ready-to-administer forms?
What alternative methods are used to obtain emergency medications in their most ready-to-
☐ ☐
administer form if they are not commercially available?
What are the acquisition methods for obtaining emergency medication dosage forms in the event
☐ ☐
of a shortage?
Has the pharmacy provided any staff training regarding the application of expiration dates to
☐ ☐
emergency medication vials when they are opened?
How do you ensure that all medications are correctly labeled or stored? Who is responsible for
☐ ☐
stocking medications?
How do you ensure the medications are stored per manufacturer’s recommendations? Per your
☐ ☐
policies?
How do you ensure that the correct temperature is maintained in the medication refrigerator? ☐ ☐
What do you do if you discover that the medication refrigerator temperature was not
maintained? Who is responsible for placing a beyond-use date on medications taken out of the ☐ ☐
refrigerator to be stored at room temperature?
How does the organization prevent unauthorized access to medications? How often are the logs
☐ ☐
associated with medications reviewed?
What type of emergency backup does your organization have for maintaining the proper storage
of essential medications, including those that need to be stored within proper temperatures? ☐ ☐
Does your organization have a policy relate to this?
Where do you store medications that are transported to and used in patients’ homes? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How do you ensure that the medications you transport are kept at proper temperatures? ☐ ☐
Have you made medication storage a part of your patient and caregiver education? If you have,
☐ ☐
how do you impart that information?
How are medications managed in the operating area? Who has access to the medication cart and
☐ ☐
how is that monitored and controlled?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
What are the high-alert and hazardous medications you keep in the facility? ☐ ☐
Please provide a list of the high-alert medications and hazardous medications that your
☐ ☐
organization handles.
What specific high-alert drug is most commonly used at your organization? What is the most
☐ ☐
commonly used hazardous medication at your organization?
How do you ensure that medications are not placed in the wrong locations? How do you monitor
☐ ☐
for this?
What do you do when you do not have enough space to store all your medication supplies? In
☐ ☐
such a situation, what do you do with high-risk items such as injection needles?
How does the organization prevent unauthorized access to high-alert and hazardous medications?
☐ ☐
How often are the logs associated with these medications reviewed?
How are staff made aware of the medications identified as high-alert and hazardous? ☐ ☐
Is the high-risk designation documented in the medical record for patients on high-alert
☐ ☐
medications?
What education and training do you provide to staff regarding medication safety and issues
related to high-alert and hazardous medications? Does it include all the components of the ☐ ☐
organization’s policy?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What would you do if you had questions about a high-alert or hazardous medication? ☐ ☐
How are the staff selected to care for patients receiving high-alert or hazardous medications? ☐ ☐
How would management know if a staff member without the required training was assigned to
☐ ☐
care for a patient receiving a high-alert or hazardous medication?
What improvements have been made to the medication management system for high-alert and
☐ ☐
hazardous medications? How are these improvements sustained? How do you know?
Are you aware of any adverse drug reaction reports concerning the use of high-alert medications
☐ ☐
in the past year? If so, what follow-up has been done?
Are any special precautions required for insulin storage? [N/A for BHC] ☐ ☐
What is the organization’s policy regarding proper storage of insulin? [N/A for BHC] ☐ ☐
What high-risk processes related to insulin have been identified? [N/A for BHC] ☐ ☐
What processes are in place to minimize mix-ups of different types of insulin? [N/A for BHC] ☐ ☐
Is unfractionated heparin a high-alert medication identified for this organization? How did you
decide on that designation? How did you decide which of the various heparin preparations should ☐ ☐
be available in this organization?
Please show me how and where you store heparin in the pharmacy. ☐ ☐
Where are the nearest spill kits located? What does a kit contain? What are the procedures
☐ ☐
regarding use of the kit for hazardous medication spills?
What is organization policy regarding the use of personal protective equipment (PPE) during
☐ ☐
chemotherapy administration?
How are staff who work in this area trained and deemed competent for the administration of
☐ ☐
chemotherapy medications? Please show documentation of this assessment.
What part do you play in making sure chemotherapy is used safely in this organization? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
How has the use of look-alike/sound- alike medications been made a part of your policies and
☐ ☐
procedures?
How did you develop your look-alike/sound- alike medication list? How often do you review and,
☐ ☐
if warranted, update the list?
What precautions and practices are in place to prevent medication errors when look-alike/sound-
☐ ☐
alike medications are ordered?
How do you store look-alike/sound-alike medications? What about sample medications that are
☐ ☐
look-alike/sound-alike?
What is your process to verify that the correct look-alike/sound-alike medications are
☐ ☐
administered?
What training and information do you share with staff about look-alike/sound-alike medications? ☐ ☐
What data has your organization collected on adverse events related to look-alike/sound-alike
medications? What has been done in response to that data? Are improvements in place to ☐ ☐
manage risks?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Who
has
oversight
in
making
sure
policies
and
procedures
regarding
the
management
of
anticoagulants
are
followed?
☐
☐
What
are
the
organization’s
policies
and
procedures
for
anticoagulant
therapy?
How
were
these
policies
developed?
What
evidence-‐based
guidelines
were
used?
Who
was
involved
in
the
☐
☐
development?
How
is
compliance
with
anticoagulant
policies
evaluated?
What
improvements
have
been
made
as
a
result
of
evaluation?
☐
☐
What is the organization’s policy for monitoring patients on anticoagulants? ☐ ☐
What
is
your
approach
to
medication
management
as
it
relates
to
high-‐risk
processes
such
as
anticoagulant
therapy?
☐
☐
How
is
anticoagulant
medication
dispensed?
Is
heparin
provided
in
manufacturer-‐prepared
premixed
infusions?
Is
warfarin
provided
in
unit-‐dose
tablets
in
exact
doses?
☐
☐
How are doses adjusted? Who adjusts doses? Are they adjusted according to protocol? ☐ ☐
How
do
you
ensure
that
new
staff
is
aware
of
the
standard
protocol
for
warfarin
dosing?
How
is
compliance
with
protocol
monitored?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How
do
you
determine
a
patient’s
baseline
coagulation
status
for
warfarin?
Where
in
the
medical
record
is
that
documented?
May
I
see
it,
please?
☐
☐
Are
there
special
requirements
for
infusing
heparin?
Explain
the
steps
in
the
administration
process.
☐
☐
What
steps
has
your
organization
taken
to
reduce
anticoagulant
compounding
and
labeling
errors?
☐
☐
How might a patient receive heparin in error? What processes are in place to prevent this? ☐ ☐
What
resources
are
you
using
to
help
manage
potential
food
and
drug
interactions
with
anticoagulants?
☐
☐
Patient: Has someone on staff talked with you about the proper way to take warfarin? ☐ ☐
Patient:
Has
someone
on
staff
talked
with
you
about
taking
other
medications
while
you
are
taking
warfarin
and
the
potential
for
interactions?
☐
☐
Patient:
What
information
have
you
received
about
your
diet
and
its
effect
on
the
anticoagulant
medication
you’ll
be
taking
after
discharge?
☐
☐
Patient:
Have
you
been
trained
in
recognizing
the
symptoms
and
implications
of
bleeding?
What
should
you
do
if
bleeding
or
clotting
occurs?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Who orders tests and makes referrals in your organization? How do you document when a test
☐ ☐
order is made?
How are patients informed of any necessary tests or referrals? How are patients educated about
☐ ☐
the test or referral?
How do orders get communicated to the laboratory? Is there any variation between
units/departments or providers in how this is done? Must all orders be written? If there are verbal ☐ ☐
orders, how are they validated?
What kind of system is used to communicate test results between the laboratory and the areas of
☐ ☐
the organization that order the tests?
What tracking system do you have in place to follow up on tests and results? Who is responsible
☐ ☐
for this? Who has access to your tracking system?
Who interprets the test results, and how are they sent to the ordering practitioner or provider? ☐ ☐
What actions take place after a result or report has come back from the lab? How do you monitor
☐ ☐
that tests are performed as ordered?
What happens if the result is abnormal? How do you document an abnormal result? What
☐ ☐
happens if the result is normal? How do you document a normal result?
How are patients informed of an abnormal result? How are patients informed of a normal result? ☐ ☐
What is your process for stat tests? How do the orders come into the lab? How do you ensure that
☐ ☐
all orders are completed? How is delivery acknowledged? How are results shared?
How are physicians informed when a stat test result is transmitted to the emergency department? ☐ ☐
What interventions are you using to reduce risk in the communication process between the
☐ ☐
laboratory and the unit/department/provider ordering the test?
What procedures are in place to protect health information transmitted between the laboratory
☐ ☐
and other areas of the organization?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Please provide the laboratory policies and procedures related to this test. ☐ ☐
What is the organization’s required time line for reporting critical results/values? ☐ ☐
How do you ensure that the critical values you report are accurate? Where are the reference
☐ ☐
ranges for your test results?
How do you ensure the privacy of test results? What process is in place to secure your electronic
☐ ☐
records?
How do you document the quality control for each laboratory test? How do you monitor it for
completeness? What type of external reporting do you have in place? What reports do you ☐ ☐
receive?
Do you have provider-performed microscopy testing? How are physicians trained to perform
☐ ☐
these tests?
Please show me your written laboratory equipment inventory. How do you select equipment to
☐ ☐
add to your inventory? How is staff involved?
What documentation do you have in relation to laboratory instrument maintenance? How long do
you keep the records for performance maintenance and function checks? How long do you keep ☐ ☐
the records for repairs and parts replacements?
What records do you keep for laboratory equipment quality control, calibration, calibration
verification, and correlation? Do they include records for automated volumetric equipment? Can
you please show those records? ☐ ☐
May I review the laboratory procedures, quality control, calibration, calibration verification, and
☐ ☐
maintenance and temperature records in the clinical laboratory for the hematology analyzers?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
Where are blood warmers located and how are they maintained to ensure they are ready for use
☐ ☐
as needed?
What are the laboratory policies and procedures for emergency release of blood? ☐ ☐
How do you monitor the blood utilization and criteria for transfusion? ☐ ☐
How does your laboratory perform the quality control in the transfusion services? ☐ ☐
Will you please show me the temperature logs for your storage refrigerators? ☐ ☐
How are the blood products stored? May I see the refrigerator used for this? ☐ ☐
What is your policy regarding storage of nonlaboratory items in the laboratory, including the
☐ ☐
refrigerators?
What would you do if you splashed a chemical in your eye during laboratory work? ☐ ☐
How do you provide reports for proficiency testing of laboratory staff? May I please see
☐ ☐
documentation of proficiency testing?
How might a discrepancy exhibited in the proficiency test results have affected patient results?
☐ ☐
How should your current process be modified, based on the proficiency test results?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Who is responsible for establishing and updating laboratory policies and procedures for cytology? ☐ ☐
What
data
and
statistics
do
you
collect
or
produce
in
relation
to
your
cytology
service?
How
is
this
☐
☐
reported
and
documented?
How
is
this
data
used
for
performance
improvement?
What quality improvement processes have you incorporated to improve the cytology service? ☐ ☐
How
do
you
set
workload
limits
and
parameters
for
cytology,
particularly
for
primary
slide
☐
☐
screening?
Where
is
this
documented?
How
do
you
determine
maximum
24-‐hour
limits?
How do you monitor workload limits and how often do you evaluate and modify them? ☐ ☐
May
I
please
see
the
laboratory
policies
and
procedures
for
cytology
specimen
collection,
☐
☐
identification,
preservation,
transport,
and
evaluation?
How
do
your
processes
of
staining,
interpretation,
and
review
differ
for
gynecologic
and
☐
☐
nongynecologic
specimens?
Who
performs
the
reviews?
How are cytology results sent to whomever ordered the test or will be using the results? ☐ ☐
What happens when an incorrect test is reported? How is this response documented? ☐ ☐
How do you provide reports for proficiency testing of laboratory staff in cytology? ☐ ☐
What
staff
training
and
education
do
you
provide
in
relation
to
cytology?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Who is responsible for maintaining your CLIA certificates? Who has oversight responsibility for all
☐ ☐
testing in the organization, including waived testing?
What oversight responsibility does the laboratory have in relation to point-of-care testing? ☐ ☐
Can you please describe your policies and procedures in relation to waived testing? How is
☐ ☐
implementation of these monitored and, as needed, modified or improved?
How do you know when waived testing is needed? What is your process to communicate and
☐ ☐
respond to orders for these tests?
How do the laboratory and the nursing staff communicate with one another for point-of-care
☐ ☐
testing concerns?
What information do you communicate with the patient during point-of-care testing? ☐ ☐
Where are levels taken during point-of-care testing recorded? How are they reported? ☐ ☐
What type of competency assessment have you received for waived testing? ☐ ☐
Please provide the annual competency for blood glucose waived testing. ☐ ☐
Please provide the facility’s waived testing policy related to monitoring blood glucose. ☐ ☐
What is your quality control process? What are these processes based upon? ☐ ☐
What is the difference between the quality control process you perform for noninstrument-based
☐ ☐
waived testing and instrument-based waived testing?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
How does your organization work with tissue banks, eye banks, and organ procurement
☐ ☐
organizations? Do you have a written agreement?
Who developed your organ donation policy? What is included in that policy? ☐ ☐
Who is the person designated by the organization to talk to patients and families about tissue and
organ donations? What are that person’s responsibilities and how is that person trained to ☐ ☐
perform them?
Please describe the process for accepting and storing tissue. How much variation is allowed in the
☐ ☐
process?
How is tissue transported to the surgical area? Who transports it and by what means? ☐ ☐
How does the tissue get taken to the surgical area? Who takes it and by what means? ☐ ☐
Where do you store tissue in the surgical area? May I see your storage equipment, please? ☐ ☐
How do you monitor tissue for proper tissue storage? What happens if the tissue storage
☐ ☐
equipment temperature rises above acceptable limits?
What happens if the tissue storage equipment fails? What backup processes are in place, if any? ☐ ☐
May I see tissue storage equipment temperature records/logs that document the time the tissue
☐ ☐
was placed in inventory to the time the tissue was implanted?
What happens if the tissue storage equipment temperature rises above acceptable limits? ☐ ☐
May I see tissue storage equipment temperature records from the time the tissue was placed in
☐ ☐
inventory until the tissue was implanted?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What are the procedures for reviewing tissue tracking in case of adverse outcomes? ☐ ☐
How do you verify that the tissue supplier has a current federal and state tissue-bank license? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
What qualifications are required for the MRI technologists? How do you verify staff qualifications? ☐ ☐
What guidelines are the imaging protocols based upon? Who reviews and approves them? How
☐ ☐
are they kept current?
How are orders for MRIs communicated to the diagnostic imaging area/center? ☐ ☐
What is the policy regarding sedation of MRI patients? Please provide the policy for review. ☐ ☐
What does the MRI patient prescreening include? How is it different for pediatric patients? How is
☐ ☐
staff screened? What if the patient responds affirmatively to any of the screening questions?
How are the safety zones marked in the MRI suite? How do you control access to the MRI area? ☐ ☐
What sort of training have you received regarding safety in the MRI suite? ☐ ☐
Did your training for the MRI suite include processes for caring for non-English-speaking patients? ☐ ☐
What sort of training have you received for emergency MRI shutdowns? ☐ ☐
How do you respond to patient emergencies in the MRI suite? Can you provide examples? ☐ ☐
What quality control activities do you perform on the MRI equipment to ensure that it is
☐ ☐
functioning properly?
Please provide the quality control documentation and the annual physicist’s report for review. ☐ ☐
How do you use data collected on adverse events in the MRI suite? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Who is responsible for risk management activities in the organization? Is this person also
responsible for intervening in cases of threat to life, health, or damage to equipment or buildings? ☐ ☐
If not, who is responsible for that? [N/A for OBS and OME]
Please describe the process for creating the environment of care management plans. [N/A for OBS
☐ ☐
and OME]
Does your organization have environment of care management plans covering all of the
☐ ☐
environment of care functional areas, such as fire safety and utilities? [N/A for OBS and OME]
How do your environment of care management plans focus on risk management? [N/A for OBS
☐ ☐
and OME]
Do the environment of care management plans include objectives, performance monitors, and
scope definitions? Do they cover all organization sites, including any leased sites? Do they explain ☐ ☐
briefly how relevant standards and EPs are met? [N/A for OBS and OME]
Do your environment of care management plans identify those responsible for completing specific
☐ ☐
tasks within required time frames? [N/A for OBS and OME]
How does your organization evaluate your environment of care management plans? How often
do you perform an evaluation? Who participates in the evaluation? Does your organization ☐ ☐
document the date of evaluations? [N/A for OBS and OME]
How does your organization ensure that the evaluation process occurs in a timely way? [N/A for
☐ ☐
OBS and OME]
Does your organization compare the evaluations of the environment of care management plans
☐ ☐
against the minutes of your improvement committee? [N/A for OBS and OME]
How do environment of care leaders communicate the results of the management plan evaluation
process to organization leadership? [N/A for OBS and OME]
☐ ☐
How do environment of care leaders use the environment of care management plan evaluations
☐ ☐
as a starting point for further conversation? [N/A for OBS and OME]
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
Senior Leader: How do you feel about the environment of care management plan evaluations?
Are the environment of care management plan evaluations easy to read and understand? What
conversations occur about environment of care issues, based on the environment of care
☐ ☐
management plan evaluations? [N/A for OBS and OME]
Senior Leader: Describe the organization’s main environment of care issues. Are those part of the
☐ ☐
management plans? [N/A for OBS and OME]
How do you monitor the environment of care to ensure a safe, functional environment? ☐ ☐
How do incidents get reported? Who receives incident reports? What is the process to enter data
☐ ☐
from the report for the purposes of data use?
Where is the incident report form located? If you cannot access an electronic version, do you have
☐ ☐
a paper version? If so, where is that located?
How do you analyze data on environment of care issues? [N/A for OBS] ☐ ☐
Are there any external agencies that you must report to? What kinds of reports do you submit?
☐ ☐
How frequently do you provide them?
What types of improvement activities have you undertaken recently to address environment of
☐ ☐
care issue? [N/A for OBS and OME]
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Do you feel the organization creates a safe and secure environment in which you can work? ☐ ☐
What type of education and procedures are in place to address workplace violence? ☐ ☐
How does the organization assess for safe workplace practice controls (ergonomics, safety
☐ ☐
equipment, personal protective equipment)?
What is the process for reporting safety and security issues? Does this information get reported to
☐ ☐
an environment of care committee and if so, how often?
Where are organizational policies regarding the environment of care located and are they
☐ ☐
available to staff?
Please provide a copy of the most recent environment of care risk assessment. ☐ ☐
How frequently does the organization review environmental data collected, committee meeting
☐ ☐
minutes, and incident reports? What do you do with the information gleaned from this review?
What interventions do you put in place to ensure that your environment is safe when the floor is
☐ ☐
being cleaned or there is inclement weather?
When you have inclement weather, what is your response plan? Who has responsibility for
☐ ☐
carrying it out? Who is responsible for tracking and implementing the plan?
How do you ensure that your signage is correct and safe for patients, staff, and visitors? ☐ ☐
How many security staff members monitor the organization during the day and evening? What
☐ ☐
is your approach to patrolling the facilities and grounds?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
Please show me where your major entrances are for the organization. How do you monitor
security at entrances and exits?
☐ ☐
How do you secure the facility? Do you lock the doors at any time? If so, why? Do you do so in a
☐ ☐
way that allows for safe egress?
What areas are designated as security-sensitive? Please take me to tour these areas. ☐ ☐
Who has access to security-sensitive areas? What do you do in the event that a staff member
☐ ☐
loses an access card or key?
How does the unit ensure the security of the elevators in security-sensitive areas like obstetrics
☐ ☐
and pediatrics?
Will you please show me any documentation you have to demonstrate training for security staff? ☐ ☐
Where are medication carts stored? How is the room secured? Does it allow safe egress? ☐ ☐
Where are your generators located? How have you secured your generators from unauthorized
access?
☐ ☐
What risks have you identified with the generators in relation to an adverse event, such as
☐ ☐
a terrorist attack or sabotage?
Have you considered the security risk implications in how you identify the generator room? ☐ ☐
Please show me where your exterior generator is located. How have you secured this
☐ ☐
generator from unauthorized access or vandalism? Who has access to the exterior generator?
Are any of the doors in the mechanical areas unmarked? Is the door that leads to the roof
☐ ☐
identified as such?
How do you mitigate risk from potential hazards in the mechanical rooms? ☐ ☐
In the event of a security problem, such as an attack or accident, how do you secure the building?
☐ ☐
What is your response?
What are the emergency lockdown procedures for all of the facilities that provide patient care? ☐ ☐
What are security staff members trained to do in the event of an active shooter? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
Has the organization conducted an emergency response exercise that initiated the organization’s
☐ ☐
Emergency Operations Plan? If so, when did this exercise take place?
During the emergency response exercise, did you monitor management of safety and security? ☐ ☐
How do you analyze the results of your emergency response exercises? Who is responsible for this
☐ ☐
analysis? How are the results communicated?
What types of data do you collect in relation to environmental safety? Who is responsible for
collecting environmental safety data? What methods do you use for collection and analysis? Who ☐ ☐
analyzes the data?
What environmental safety issues have you discovered and addressed as a result of your data
☐ ☐
collection and aggregation?
Who is responsible for planning and designing improvements resulting from environmental risk
assessments? How do you implement the improvements? How are staff members educated about ☐ ☐
the improvements? How are you monitoring results?
How do you mitigate risk from potential hazards in the mechanical rooms? ☐ ☐
Please describe how wheelchairs used by discharged patients get returned from the main
entrance to their proper storage area. How do you check the entrances for potential equipment ☐ ☐
blockages such as this?
Please show me where the wheelchairs are stored. Are any patient rooms being used for
equipment storage? If so, why? How do you ensure security for the equipment in that room?
☐ ☐
What environmental factors have you identified that could increase the risk of successful suicide
☐ ☐
or self-harm attempts in behavioral health areas? In other areas?
What kinds of environmental interventions have you put in place? How do you secure the
☐ ☐
environment to mitigate suicide and self-harm risk in behavioral health areas? In other areas?
What education do you provide to patients and families about home environment hazards? ☐ ☐
What processes are in place for responding to a patient elopement? May I see your written
☐ ☐
response plan? [NCC only]
How do you communicate the patient elopement to staff and the patient’s family? How is local
☐ ☐
law enforcement informed and involved? [NCC only]
How do you communicate and facilitate product recall (equipment, food, devices, utilities)? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
Who is responsible for ensuring the security of infants and pediatric patients in this organization? ☐ ☐
Has the organization conducted a risk assessment on infant/pediatric security and abduction?
☐ ☐
What were the results of this risk assessment?
How does the organization preserve security for infants and pediatric patients in this area? ☐ ☐
Patient or Family: Please tell me about what you have been told regarding infant/pediatric patient
☐ ☐
security.
What additional security measures do you put in place in security-sensitive areas, such as the
☐ ☐
obstetrics department?
Who has access to the obstetrics department and pediatric units? How does the organization
☐ ☐
control access to these areas?
How do you track and monitor access to security-sensitive areas like obstetrics and pediatrics? ☐ ☐
What do you do when the electronic system for controlling access to infant/pediatric care units
fails? Does the unit have manual systems in place for controlling access? Is the security system for ☐ ☐
obstetrics connected to emergency power?
Do you use a Code Pink process or similar process to alert staff to an infant/pediatric abduction? If
☐ ☐
so, please describe that process. Which staff members are involved in the process?
What is your responsibility when a Code Pink or similar process is called? What is the
☐ ☐
responsibility of your peers in this situation?
What is the role of local law enforcement in your organization’s response to an infant/pediatric
abduction? How would they be contacted if it became necessary? Who would contact them?
☐ ☐
Has the organization ever done an infant/pediatric abduction exercise? If so, in what areas of the
☐ ☐
organization? Who was involved?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
How often are exercises on infant/pediatric abduction response conducted? Please provide a copy
☐ ☐
of the most recent exercise evaluation.
Has the organization involved outside law enforcement in infant/pediatric abduction exercises? ☐ ☐
How does the unit identify potentially disruptive family situations (such as estrangement or a
custody battle) that might create risk for an infant/pediatric abduction? How is that information
shared with staff on the relevant unit? How does the unit increase security around a child
☐ ☐
involved in such situations?
What processes does the organization have in place for releasing a child to a noncustodial parent? ☐ ☐
How does the emergency department preserve the safety of infants and pediatric patients? ☐ ☐
How do you respond if a child is missing in the emergency department? Who do you notify first?
☐ ☐
Who else do you notify?
How does the organization notify internal and external security if a child is missing in the
☐ ☐
emergency department?
Does the organization lock down the emergency department in response to a missing child? If so,
how? How is the lockdown communicated to patients, families, and staff?
☐ ☐
Has the organization done exercises for children missing in the emergency department? What
deficiencies did the organization identify in those exercises? What changes have resulted in ☐ ☐
response to those exercises?
What type of education and training does the organization provide staff about infant/pediatric
security and incident response? How often is it offered? Can you please provide documentation of ☐ ☐
this education and training?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
How do you inventory your hazardous materials and waste? What do you keep on the inventory?
☐ ☐
May I see your hazardous materials and waste inventory? [N/A for BHC and OBS]
How do you check and update the inventory? How often is this done? How do you prioritize
updating the inventory? What happens when a new hazardous material is brought into ☐ ☐
the organization? [N/A for BHC and OBS]
Who has responsibility for the inventory? Who is responsible for updating it? How do you track
this responsibility? [N/A for BHC and OBS]
☐ ☐
Where is the inventory kept? Do you have any backups for it? [N/A for BHC and OBS] ☐ ☐
Do you use any kind of safety data sheets (SDSs) in the organization? If so, where do you store
them? [N/A for BHC and OBS]
☐ ☐
Do staff members know how to access safety data sheets (SDSs)? How do staff members access
an SDS when the computer is not available? [N/A for BHC and OBS]
☐ ☐
How do you update the safety data sheets (SDSs)? How do you communicate any changes or
☐ ☐
updates? [N/A for BHC and OBS]
What organization processes and procedures exist for handling hazardous material and waste? ☐ ☐
What regulatory bodies control the organization’s storage, labeling, and handling of hazardous
materials and waste?
☐ ☐
What kind of documentation do you maintain in relation to hazardous waste and materials
management? What monitoring logs or checklists do you maintain?
☐ ☐
How do you secure hazardous materials—for example, those stored on a housekeeping cart? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 4
How do you label containers of hazardous materials? How do you label containers of cleaning
products with hazardous materials? What do you do if you find an unlabeled product?
☐ ☐
How are hazardous waste products handled? How are they stored for disposal? How often are
they removed from the facility?
☐ ☐
How does the organization collect data on hazardous materials and waste spills? Are these data
☐ ☐
available for specific locations, such as the laboratory? How often do you review these data?
What kinds of data do you collect on hazardous materials and waste use and adverse events? ☐ ☐
Has there been any recent incident involving hazardous materials or waste? If so, please describe
that incident.
☐ ☐
What training does the organization provide on responding to an incident involving hazardous
materials or waste?
☐ ☐
Are you required to report hazardous materials and waste reports to any external agencies? If so,
what kinds of reports do you submit? How frequently do you provide them?
☐ ☐
What are the risks involved in splashing chemicals? What training have you had on the proper
response to a chemical splash? If a chemical splashes in your eye, what do you do?
☐ ☐
Does your organization have eyewash stations? If so, where are they located? ☐ ☐
Who is responsible for testing the eyewash stations? What do you test in the eyewash stations
and how do you test it? What do you do when the testing shows that an eyewash station is not ☐ ☐
functioning properly? Who do you contact to fix the eyewash station?
How often do you test the eyewash stations? Where do you keep testing records for the eyewash
stations?
☐ ☐
What hazardous materials do you work with? What risks are associated with the hazardous
materials? What training and education have you had on these materials? How do you access the ☐ ☐
safety data sheets (SDS) for this material? [N/A for BHC and OBS]
What personal protective equipment (PPE) do you wear to protect yourself from hazardous
materials and waste?
☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 4
What would happen if someone spilled hazardous materials? How would the spill be cleaned and
disinfected? What personal protective equipment (PPE) would be necessary when cleaning up the ☐ ☐
spill?
What is the housekeeping department’s role in cleaning up spills, specifically those related to
hazardous cleaning materials such as bleach?
☐ ☐
How would you notify other staff, patients, and leadership about a hazardous materials spill? ☐ ☐
How would you respond to individuals exposed to hazardous spill materials? How would you
prevent exposure to others in the organization? Would you need to evacuate the area of the spill?
☐ ☐
What training and education have you received on hazmat spill response? ☐ ☐
Who would you call to address a really large hazmat spill? When do you notify outside authorities,
such as the fire department? What is the organization’s relationship with the fire department ☐ ☐
regarding hazmat response?
Do you have a hazmat response team? Who is on the hazmat response team? ☐ ☐
How are hazmat team members trained? What is the team’s response to a hazmat spill? ☐ ☐
Has the organization ever done a hazmat drill that included an individual who needs
decontamination?
☐ ☐
Please describe the general storage requirements for the chemicals in the mechanical rooms. ☐ ☐
Are the boiler and air-handling equipment rooms typically where the chemicals needed for
maintaining the equipment are stored? If so, how was it determined that these chemicals could ☐ ☐
be stored in the same area as the equipment?
How is the maintenance staff supervised when working with or stocking the chemicals stored in
the mechanical rooms?
☐ ☐
Who keeps the safety data sheets (SDSs) on chemicals needed for maintaining equipment? Please
provide the SDSs on the chemicals stored in the mechanical rooms. [N/A for BHC and OBS]
☐ ☐
How do you inform staff of the SDS requirements for chemicals stored in the mechanical rooms?
☐ ☐
What type of refresher education is held? [N/A for BHC and OBS]
Do you conduct regular inspections for spills or leakage of chemicals in the mechanical rooms? Do
you have documentation of those inspections?
☐ ☐
Please show me your written procedures regarding spills of chemicals in the mechanical rooms. ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 4
Do you know what to do in the case of a chemical spill? What is the special code to call if a
chemical spill occurs?
☐ ☐
Do you know whether any specific chemicals require specialized handling in case of a spill? ☐ ☐
Where is the protective equipment for handling chemical spills in the mechanical rooms? ☐ ☐
What are the organization’s policies on infectious waste disposal? Who develops these policies?
How often are these policies reviewed?
☐ ☐
What training does the organization provide to staff on infectious waste disposal policies? ☐ ☐
What is the proper way to discard infectious waste, such as a used syringe or soiled gauzes? ☐ ☐
What personal protective equipment (PPE) should you wear when handling infectious waste? ☐ ☐
What training does the organization provide on infectious waste? How often does that training
occur? How does the organization measure whether that training is effective?
☐ ☐
Where do you usually pick up bags of infectious waste? What types of materials are in the bags? ☐ ☐
What personal protective equipment (PPE) do you wear when you handle a hazmat bag of
infectious waste? How do you ensure infection control when transporting the bag? What training ☐ ☐
and education have you received on infectious waste disposal?
How does the organization store infectious waste until the contracted infectious waste hauler
arrives for pickup?
☐ ☐
How do you document when infectious waste arrives? How do you document when the
contractor picks up the infectious waste for disposal?
☐ ☐
Who is the organization’s hauling contractor for infectious waste? How did the organization
choose that contractor?
☐ ☐
Has the organization done a risk assessment on radiation safety? If so, what were the results of
☐ ☐
that assessment? [N/A for BHC, OME, NCC, and OBS]
How do you remove radioactive material from the facility? How do you dispose of such material?
What personal protective equipment (PPE) do you wear when removing and disposing of ☐ ☐
radioactive material? [N/A for BHC, OME, NCC, and OBS]
How does a dosimeter badge work? How do you interpret the information on the badge? [N/A for
BHC, OME, NCC, and OBS]
☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 4 of 4
May I please see your written fire response plan? How often do you review and update it? ☐ ☐
How does the organization create and maintain the fire response plan? Who is involved in this
☐ ☐
process?
What is the role of the fire response team in the fire response? ☐ ☐
What is the organization’s approach to fire response? How often is this approach tested? ☐ ☐
When would the unit make the decision to evacuate? Who would make that decision? ☐ ☐
How would the unit horizontally evacuate? How would the unit vertically evacuate? Where would
the unit meet up after the evacuation?
☐ ☐
How is the staff directed to maintain communication with family members and other organization
☐ ☐
staff during a fire evacuation?
What training and education does the staff receive on the fire response plan? How often is that
☐ ☐
training provided? Is that training documented?
How often are staff understanding and familiarity with the plan tested? ☐ ☐
If there were a fire in the organization right now, what would you do? How would you ensure the
☐ ☐
safety of patients, visitors, and staff? What would you do about items stored in the corridor?
What would your response be if the fire were on a different floor from yours? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
When was the last fire drill for your work area? Please show me your log of fire drills. Who is
☐ ☐
responsible for tracking and updating this information?
Describe a recent fire drill in which you participated and what the outcomes of that drill were. ☐ ☐
Did the organization involve the fire department in the drill? Does the organization notify the fire
department before the drill so it doesn’t respond?
☐ ☐
How did you evaluate the success of the drill? What did the organization learn from the drill? ☐ ☐
What does the organization do with the information gleaned from fire drill evaluations? Does the
☐ ☐
organization use the information for performance improvement?
In the last fire drill, what was something the organization learned? What corrective actions were
☐ ☐
taken as a result of the drill? Who followed through on those corrective actions?
In the event of an unexpected response or outcome to a fire drill or fire incident, how do you
☐ ☐
implement an improvement? Can you please give me an example of this?
Where is the closest fire alarm? Where is the closest fire extinguisher? ☐ ☐
Where are the visual and audible fire alarms located? Please show me an example. How often is
the equipment tested?
☐ ☐
What equipment does the fire response team use to help contain a fire? Where does the team
☐ ☐
access that equipment?
Please show me where your fire safety equipment is. Where do you label dates and
☐ ☐
other information about recent testing and monitoring on the equipment?
May I see the policy for smoke detector testing, maintenance, and battery replacement? Please
☐ ☐
provide the documentation indicating that you have followed this policy.
* Fire safety and life safety are both terms that relate to fire protection, but they differ for the purposes of Joint Commission
requirements: Fire safety requirements are in the “Environment of Care” chapter and refer to fire protection—and fire
response—that is dependent on human intervention (fire drills and fire safety equipment, maintaining means of egress and
fire exits). Life safety requirements are in the “Life Safety” chapter and refer to fire protection dependent on building
features (alarm and sprinkler systems, construction, building design, hardware). The standards in the “Life Safety” chapter are
based on the 2012 edition of the Life Safety Code, issued by the National Fire Protection Association. Life Safety Code® is a
registered trademark of the National Fire Protection Association, Quincy, MA.
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
May I see your medical equipment inventory? How does the organization create its medical
equipment inventory? Who is involved?
☐ ☐
How does the organization determine which medical equipment to include in its inventory? ☐ ☐
How often does the organization review and update the inventory? ☐ ☐
How has the organization identified medical equipment that is considered high-risk? ☐ ☐
Do you have defined activities and frequencies for maintaining, inspecting, and testing all medical
equipment on the inventory?
☐ ☐
How has the organization identified whether medical equipment is maintained per
manufacturers’ recommendations or an alternative equipment maintenance (AEM) program? ☐ ☐
[CAH and HAP only]
For equipment that is maintained through an AEM program, please provide documentation by a
☐ ☐
qualified individual of the written criteria used to develop this program. [CAH and HAP only]
What is your process to safely store, label, and handle medical equipment? ☐ ☐
What safety guidelines and processes do you follow for specific types of medical equipment? ☐ ☐
What process do you follow for staff to report any issues with medical equipment (missing,
☐ ☐
needing repair, and so on)?
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
Please describe your processes for initial inspection of equipment and inspection after major
repair.
☐ ☐
Have you ever had issues of lost or missing medical equipment? If so, what is your process to
☐ ☐
resolve it?
Where do you keep documentation for maintenance, inspection, and testing of medical
☐ ☐
equipment?
How does the organization ensure that all medical equipment is appropriately maintained? ☐ ☐
How does the organization track medical equipment maintenance schedules and information? ☐ ☐
What training is provided to the individuals charged with maintaining the equipment? ☐ ☐
How do you communicate with the staff in charge of medical equipment maintenance? ☐ ☐
How do you communicate with medical equipment users about equipment maintenance? ☐ ☐
How does the organization handle medical equipment that is serviced off-site? ☐ ☐
Who is the contractor the department uses to maintain the equipment? How do you
☐ ☐
communicate with this contractor?
How do you get the equipment to the contractor? What do you do to ensure that equipment
☐ ☐
returned to your location is in working order?
How does the organization ensure that the contractor is doing a good job? ☐ ☐
Staff Member: Could you point to a key piece of equipment that you use regularly? How often is it
used and what maintenance is performed on it? How would you know if there is a need to repair ☐ ☐
anything? What kind of competency training have you had to use this piece of equipment?
Who do you contact with questions about medical equipment functions and malfunctions? ☐ ☐
If you use medical equipment, such as an infusion pump in the home environment, how do you
maintain the equipment? How are the supplies for medical equipment delivered to the patient in
☐ ☐
the home? Who checks whether there are expiration dates on the supplies? What do you do in
the event of a problem with the equipment? [OME only]
What kind of patient education and training materials do you provide in relation to medical
☐ ☐
equipment used in the home? [OME only]
Patient: What has your experience been with this home medical equipment organization? Have
☐ ☐
you been able to get help with answers to your concerns or questions? [OME only]
What is the organizational process when patients bringing their own medical equipment, such as
CPAPs (Continuous Positive Airway Pressure)? What kind of training have you received to help you ☐ ☐
check the equipment, if necessary?
What is the organizational process when medical equipment failure leads to a poor patient
☐ ☐
outcome? How do you secure the equipment? How do you isolate the equipment?
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
How does the clinical staff know who to notify about the medical equipment failures? ☐ ☐
How do you maintain the safety of patients during failure of medical equipment? ☐ ☐
What training have you had on emergency clinical interventions during medical equipment
☐ ☐
failures?
Describe an event in which a piece of medical equipment failed. What circumstances led to the
☐ ☐
event? What was the immediate response to the incident? What was the long-term response?
Are you satisfied with responses to medical equipment failures? How well do the various
individuals and/or departments work together during such events? What have you learned from ☐ ☐
such incidents to prevent future equipment failures?
Does your organization report incidents of medical equipment failure? If so, who creates the
☐ ☐
report and how? To whom is it submitted?
Has the organization ever used the data in the medical equipment database to track
☐ ☐
performance? If so, how has that data been used to improve performance?
Do the defined activities and frequencies not only include testing, inspection, and maintenance
☐ ☐
but also cleaning procedures?
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
May I see your utility component inventory? How does the organization create its utility
☐ ☐
component inventory? Who is involved?
How does the organization determine which utility components to include in its inventory? ☐ ☐
How often does the organization review and update the inventory? ☐ ☐
How has the organization identified utility components that are considered high-risk? ☐ ☐
Do you have defined activities and frequencies for maintaining, inspecting, and testing all utility
☐ ☐
components on the inventory?
How has the organization identified whether utility components are maintained per
manufacturers’ recommendations or an alternative equipment maintenance (AEM) program? ☐ ☐
[CAH and HAP only]
For utility components that are required to be maintained per manufacturers’ recommendation,
☐ ☐
please provide documentation that those activities and frequencies are being met.
For utility components that are maintained through an AEM program, please provide
documentation by a qualified individual of the written criteria utilized to develop this program. ☐ ☐
[CAH and HAP only]
What kind of training and orientation does the organization provide in relation to utility systems? ☐ ☐
Please show me the organization’s written procedures for responding to utilities system
☐ ☐
disruptions or failures. Who creates these procedures? How often are they reviewed?
Are clinical staff trained on procedures for responding to utilities system disruptions or failures? ☐ ☐
What would you do in the event of a utility failure, such as a medical gas failure? ☐ ☐
How would you ensure the safety of patients during a utility failure? [N/A for LAB] ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 4
How would you communicate with the facilities management department during a utility failure? ☐ ☐
How are lighting, ventilation, and temperature controlled in the case of an electrical outage? ☐ ☐
How would you shut down a particular system on the utilities system map in the event of an
☐ ☐
emergency?
How would you notify staff in affected areas if a utility system needed to be shut down or was
☐ ☐
otherwise disrupted?
How does the organization obtain emergency repair services for utility systems disruptions? ☐ ☐
Who in the organization is qualified to shut down a utility during an emergency situation? ☐ ☐
How does the organization ensure that only qualified individuals can shut down utilities? ☐ ☐
Please show a sample of how the organization labels utilities system controls to facilitate partial
or complete emergency shutdowns. Who labels the controls? How are the labels changed if ☐ ☐
necessary? How often do you check these utilities for correct labeling?
Please show me where the shutoff panels are in this area. How can I verify whether the
☐ ☐
maintenance and labeling is up to date on the panels?
What would you do if you needed to shut off the electrical power or medical gas in this area? ☐ ☐
Who do you contact if you need to do an emergency shutdown or if you have a problem with a
☐ ☐
utility system?
What emergency planning have you conducted around utility system failures? What testing do
you do to help mitigate such failures?
☐ ☐
What failures, if any, occurred during recent testing of emergency power? How has the
☐ ☐
organization addressed those failures?
How does facility management communicate with patient care units about power outages and
☐ ☐
when power is expected to be restored? [N/A for LAB]
Please describe the plan for communication between the organization’s power plant and your
☐ ☐
area during a power outage.
What training and education regarding power outages have you received? Do you feel that this
☐ ☐
training and education adequately prepares you for power outages?
How does the staff ensure the safety of anyone in surgery at the time of a power outage? [CAH,
☐ ☐
HAP, and OBS only]
What training and education has operating room staff received on response to power outages? Is
☐ ☐
that training effective? How do you know? [CAH, HAP, and OBS only]
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 4
Does the organization activate its incident command center during a power outage? If not, why
☐ ☐
not? If yes, how does the process work?
How does the organization communicate with the power company during a power outage? ☐ ☐
Does the organization have a memorandum of understanding with its power company and any
☐ ☐
generator vendors?
When was the last time you experienced a power outage? Please describe the incidents and the
events leading up to it. How did the organization respond to the power outage? What systems
☐ ☐
transferred to emergency power? How smooth was that transfer? Was anyone harmed as a result
of this outage?
Please show me your documentation on your emergency generators. Has any recent maintenance
☐ ☐
been done on them?
How does the organization initiate emergency generator tests? What does the organization do to
☐ ☐
prepare for a generator test?
Why is it important to do a 30-minute test and a four-hour test for emergency generators? ☐ ☐
Under what load does the organization test each emergency generator? ☐ ☐
What does the organization do to test the emergency generator’s fuel oil? Track expiration dates?
☐ ☐
Replace stale fuel oil?
What training and education have staff in charge of emergency generator testing received? ☐ ☐
What is the process involved in ensuring that all emergency generator tests are accomplished in a
☐ ☐
timely manner?
What contingency plans does the organization have in place in case the emergency generator fails
☐ ☐
the test and the power goes out?
Does the organization restrict its services during an emergency generator test to minimize any
patient impact? [N/A for LAB]
☐ ☐
Do you have a secondary generator that can be in place before each four-hour generator test? ☐ ☐
How well does the organization communicate with staff about emergency generator tests? Why is
interdepartmental communication important before, during, and after these tests?
☐ ☐
How does the organization coordinate transfer switch testing with emergency generator testing? ☐ ☐
How does the organization ensure that every transfer switch is tested? ☐ ☐
How recently has the organization tested the transfer switches for emergency power? Were there
☐ ☐
areas that were supposed to be under emergency power that weren’t?
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 4
How did the organization ensure the proper design and installation of the ventilation system?
What regulations govern the design and installation of the ventilation system?
☐ ☐
How old is the ventilation system in this area? How can you tell if the ventilation system is
☐ ☐
working? What do you do if the ventilation system isn’t working?
What training and education does the organization provide on the ventilation system? ☐ ☐
In what areas does the ventilation system control airborne contaminants? Can you please show
☐ ☐
me the utility system drawings?
How does the organization set and maintain appropriate pressure relationships? ☐ ☐
How does the organization set and maintain appropriate air-exchange rates? ☐ ☐
How does the organization set and maintain appropriate filtration efficiencies? ☐ ☐
How does the organization set and maintain appropriate temperature and humidity? ☐ ☐
Who interprets the reports from the HVAC system? How do these people interpret the reports?
☐ ☐
How do they respond to those reports?
How does the organization’s HVAC alarm system work to warn of variations from appropriate
☐ ☐
system settings? How does the organization ensure that HVAC alarms are heard?
Please describe your medical gas and vacuum systems: processes, maintenance, and emergency
management (including cylinders and manifold rooms).
☐ ☐
What education and training does the organization provide on medical gas and vacuum systems? ☐ ☐
What is your organization’s process for response to elevator entrapment? How do you manage
☐ ☐
risks related to elevator entrapment?
How do you instruct and train all staff involved in oxygen safe handling, use, and delivery? How is
☐ ☐
this documented?
Would you please show me a personnel record for a staff member who has undergone
☐ ☐
competency training in relation to oxygen safe handling?
What education do your delivery technicians provide to patients receiving special medical
equipment such as oxygen? [OME only]
☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 4 of 4
9.8: Construction*
Relevant Standards: EC.02.03.01, EC.02.03.03, EC.02.06.01, EC.02.06.05, HR.01.05.03, Use Adapt
HRM.01.05.01,LD.04.03.09 Question Question
As Is for Use
Accreditation Programs/Settings: AHC, BHC, CAH, HAP, LAB, NCC, OBS, OME
NOTE: HRM standards are for BHC only.
Who was responsible for writing the construction plan? What staff members were involved in
☐ ☐
planning for it?
Do you follow any specific design guidelines for your construction plans? If so, what are they?
☐ ☐
[N/A for OBS]
Did your organization prepare a preconstruction risk assessment prior to construction? If so, may I
☐ ☐
see it? [N/A for LAB and OBS]
What risks were revealed in the preconstruction risk assessment? [N/A for LAB and OBS] ☐ ☐
Did you perform an infection control risk assessment (ICRA) prior to construction? [N/A for LAB
☐ ☐
and OBS]
How often do you evaluate your construction plan? Have you made changes to it? Were any of
the changes in response to a preconstruction risk assessment? How are those changes ☐ ☐
communicated? [N/A for LAB and OBS]
When did the project start? How long has the construction been under way? How long is it
expected to continue?
☐ ☐
Please show me the construction site. Who has oversight responsibility for this construction site?
What involvement does management at the construction site have in the ongoing activity?
☐ ☐
What changes to the environment have been put in place to accommodate the construction?
☐ ☐
How are you redirecting traffic?
Are any building exits compromised by the construction? What does the organization do to alert
staff, visitors, and patients about alternate exits? Are there signs showing alternate exits? Are ☐ ☐
patients and families ever confused when leaving the area?
What impact has the construction project had on patient care activities? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
How does the organization conduct rounds of the construction site? Who participates in these
rounds? How long do the rounds take? How frequently do the rounds occur? Do you document ☐ ☐
information observed in these rounds?
What does the construction plan dictate should happen if there are changes at the construction
☐ ☐
site? What are the appropriate channels of communication in the event of a change?
Has the organization experienced any problems in the project that could threaten the safety of
☐ ☐
patients, staff, and visitors? If so, please describe them.
How do you report a safety issue with the construction project? To whom would you report this
☐ ☐
issue?
Do you perceive increased fire protection** risks associated with the project? ☐ ☐
General Contractor: How does the construction company preserve life safety on this site? ☐ ☐
General Contractor: How do you ensure that every construction worker understands the fire
safety risks present in the project and how to minimize those risks?
☐ ☐
Construction Worker: Please describe how you preserve fire safety in this area. ☐ ☐
Is there a “no smoking” policy for the area? How is that policy enforced? ☐ ☐
Does the organization do fire drills for this area? How often does the organization do them? When
was the last one?
☐ ☐
General Contractor: When was your most recent fire drill in this area? How did it go? ☐ ☐
What training and orientation does the organization offer to construction workers? What topics
are covered in that training? How is the training provided? How does the organization ensure that ☐ ☐
construction workers understand the training?
General Contractor: What education do you provide to construction workers before and during
☐ ☐
the project? Do you document that education? If so, how?
Construction Worker: What education have you received about this project? ☐ ☐
Please describe how the organization proactively looks for Life Safety Code† deficiencies on
☐ ☐
construction sites. [N/A for OBS]
Please describe what would happen if someone discovered a Life Safety Code† deficiency on a
☐ ☐
construction site. [N/A for OBS]
How does the organization educate staff on reporting any Life Safety Code† deficiencies
encountered on a construction site? [N/A for OBS]
☐ ☐
Maintenance Worker: Describe a possible Life Safety Code† deficiency that you may encounter in
or near the construction site. How would you respond to that deficiency? How would you report ☐ ☐
the deficiency? [N/A for OBS]
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
Do you have an interim life safety measure (ILSM) policy? If so, how did the organization create its
☐ ☐
ILSM policy? Who was involved in creating this policy? Who approved this policy? [N/A for OBS]
Does your organization’s interim life safety measure (ILSM) policy involve more than just life
☐ ☐
safety deficiencies associated with construction? [N/A for OBS]
How would the organization activate the interim life safety measure (ILSM) policy? Please
☐ ☐
describe situations in which the ILSM policy would go into effect. [N/A for OBS]
How does the organization make staff members, such as maintenance personnel, aware of
the interim life safety measure (ILSM) policy, how to access the policy, and what the policy ☐ ☐
contains? [N/A for OBS]
How does the organization enforce its interim life safety measure (ILSM) policy? [N/A for OBS] ☐ ☐
Who is responsible for making decisions about the appropriate interim life safety measures
(ILSMs) for a particular project or situation? How would this person document what measures ☐ ☐
were to be used? [N/A for OBS]
How does the organization post information about the particular interim life safety measure
(ILSM) used to mitigate a deficiency? [N/A for OBS]
☐ ☐
How would the organization know to stop using an interim life safety measure (ILSM) when a
deficiency is resolved? [N/A for OBS]
☐ ☐
How does the organization notify patients, staff, and visitors about interim life safety measures
☐ ☐
(ILSMs)? [N/A for OBS]
Staff Member: What are interim life safety measures (ILSMs)? What ILSMs are in place on this
☐ ☐
construction site? Why are they in place? How do they affect your daily routine? [N/A for OBS]
What interim life safety measures (ILSMs) are in place? Will those be in place for the duration of
the construction? [N/A for OBS]
☐ ☐
How regularly do you check the site to ensure that appropriate interim life safety measures
(ILSMs) are in place? Have you used additional staff to help check and test whether the interim ☐ ☐
life safety measures are working? [N/A for OBS]
* Applies to demolition, construction, and renovation projects
† Fire safety and life safety are both terms that relate to fire protection, but differ for the purposes of Joint Commission
requirements: Fire safety requirements are in the “Environment of Care” chapter and refer to fire protection that is
dependent on human intervention (fire drills and fire safety equipment, maintaining means of egress and fire exits). Life
safety requirements are in the “Life Safety” chapter and refer to refer to fire protection dependent on building features
(alarm and sprinkler systems, construction, building design, hardware). The standards in the “Life Safety” chapter are based
on the 2012 edition of the Life Safety Code, issued by the National Fire Protection Association. Life Safety Code® is a registered
trademark of the National Fire Protection Association, Quincy, MA.
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
Who is responsible in your organization for emergency management planning? How does
leadership support that individual or team in emergency preparedness activities throughout the ☐ ☐
organization?
May I see the Emergency Operations Plan manual and any other paperwork related to exercises
☐ ☐
or actual emergency responses?
How does the organization involve senior leadership in the emergency management planning? ☐ ☐
How does the organization involve community partners in the process of emergency planning? ☐ ☐
How do you ensure that your staff is aware of and understands the Emergency Operations Plan? ☐ ☐
What kind of training have you provided to your staff on emergency preparedness and response? ☐ ☐
Does this organization have an interactive relationship with community responders? If so, how
often do people from the organization and emergency responders get together to talk about ☐ ☐
emergency preparedness, response, and recovery?
How does your organization create its hazard vulnerability analysis (HVA)? ☐ ☐
How is the hazard vulnerability analysis (HVA) used to define mitigation and preparedness
☐ ☐
activities?
What are the organization’s top prioritized risks as identified by the hazard vulnerability analysis
(HVA)? Give an example of how the organization would address each of the six critical areas of
emergency management during likely emergencies: communication, assets and resources, safety ☐ ☐
and security, staff responsibilities, utilities management, and patient clinical and support
activities.
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Does the organization use an incident command system, such as NIMS or HICS, for
communication during an emergency? If so, please describe the incident command system the ☐ ☐
organization uses.
Who is on the incident command team? Which team members are stationed in the command
☐ ☐
center during an emergency?
How is the organization oriented to the purpose and functions of the Incident Command System? ☐ ☐
How does the organization activate the incident command center during an emergency response
☐ ☐
event/exercise? Set it up? Equip it?
Incident Commander: What training have you received about how to be an incident commander?
☐ ☐
Did that training help you during recent emergencies and exercises?
Incident Commander: Why did the organization choose you to be the incident commander? Is
☐ ☐
there a trained backup person in case you are unavailable?
Incident Commander: Please show me the incident command center. Why did the organization
choose this location for the command center? Does the organization have a secondary location?
☐ ☐
Why did the organization choose that location? Has the organization ever done an emergency
management exercise using the alternative location?
Staff Member: Where is the incident command center? Who works there? ☐ ☐
How do staff members communicate throughout the organization and between locations during a
phone outage?
☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 2
What plans are in place to ensure that medications are provided uninterrupted during an
emergency? How is the pharmacy included in this planning?
☐ ☐
What plans are in place to identify risks related to potential cyber emergencies (system failures or
system attacks) that could impact patient care? How are cyber failures or attacks detected? How
☐ ☐
are patient care services maintained when information technology service downtimes (scheduled
or unscheduled) occur?
What is the emergency management plan for monitoring the statuses of patients and their
locations in the event of a disaster requiring evacuation? How will you communicate patient ☐ ☐
status and needs to organizations/locations receiving evacuated patients?
What types of emergency supplies and equipment does the organization keep in this area? How
☐ ☐
will you communicate need for more during an emergency?
During the last emergency response, were the number and types of supplies in this area
☐ ☐
adequate? Was anything missing? If so, what?
What would the organization do if it projected that it could not receive support from the
community for 96 hours during an emergency? Please describe this scenario as it relates to the ☐ ☐
organization’s top three likely emergencies, as defined in your hazard vulnerability analysis (HVA).
* An emergency is an unexpected or sudden event that significantly disrupts the organization's ability to provide care, or the
environment of care itself, or that results in a sudden, significantly changed or increased demand for the organization's
services. Emergencies can be either human-made or natural (such as an electrical system failure or a tornado), or a
combination of both, and they exist on a continuum of severity. A disaster is a type of emergency that, due to its complexity,
scope, or duration, threatens the organization's capabilities and requires outside assistance to sustain patient care, safety,
or security functions. Electrical system failures and power outages are addressed in tracer question sets covering utility
systems.
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 2
Has
your
organization
conducted
a
recent
exercise
to
test
your
emergency
planning?
If
so,
when
did
this
exercise
take
place?
☐
☐
How
do
you
evaluate
and
analyze
the
results
of
your
emergency
response
exercises?
Who
is
responsible
for
this
analysis?
How
is
the
analysis
documented?
How
are
results
communicated?
☐
☐
What does the organization do with the information gleaned from the evaluations? ☐ ☐
What
deficiencies
has
the
organization
identified
in
recent
emergency
response
exercises?
How
has
the
organization
responded
to
those
deficiencies?
☐
☐
Please
tell
me
about
some
of
the
modifications
you
have
made
to
your
emergency
plans
in
response
to
recent
emergency
events/exercises.
☐
☐
Staff
Member:
Whom
did
you
report
to
during
the
last
emergency
response
event/exercise?
Did
you
know
you
would
report
to
that
person
before
the
event/exercise?
☐
☐
Staff
Member:
What
were
your
responsibilities
during
the
last
emergency
response
event/exercise?
Were
you
comfortable
with
those
responsibilities?
☐
☐
How
does
the
organization
address
the
six
critical
areas
of
emergency
response
during
events/exercises:
communication,
assets
and
resources,
safety
and
security,
staff
responsibilities,
☐
☐
utilities
management,
and
patient
clinical
and
support
activities?
Do
you
plan
for
decontamination
during
events/exercises?
If
so,
how
did
the
decontamination
efforts
go
in
the
last
event/exercise?
☐
☐
Does
your
organization
designate
alternative
care
sites
for
use
in
an
emergency?
If
so,
how
were
these
sites
chosen?
In
what
situations
would
these
sites
be
used?
Has
the
organization
ever
done
☐
☐
an
exercise
using
an
alternative
care
site?
Have
you
conducted
any
exercises
around
a
potential
influx
of
infectious
patients?
How
have
you
engaged
staff
in
the
process?
Have
you
analyzed
the
effectiveness
of
response
to
these
exercises?
☐
☐
Have
you
made
improvements
based
on
this
analysis?
[CAH
and
HAP
only]
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
How does the organization grant disaster privileges to volunteer licensed independent
☐ ☐
practitioners and other volunteer practitioners?
Who is involved in the process for granting disaster privileges to volunteer licensed independent
practitioners and other volunteer practitioners? How does the organization document this ☐ ☐
responsibility, and where does it document it?
When can the organization grant disaster privileges? To whom can it grant such privileges? ☐ ☐
What type of information is the organization required to get before the privileged volunteer can
begin treating patients? How does the organization verify a volunteer’s licensure, certification, or ☐ ☐
registration required for particular practices?
How does the organization obtain primary source verification of licensure? When does this
happen? What would the organization do if it could not obtain primary source verification within ☐ ☐
72 hours?
How does the organization ensure oversight of the care, treatment, and services provided by a
☐ ☐
privileged volunteer?
How does the organization assess performance and determine whether to continue granting
☐ ☐
disaster privileges to an individual? Who is in charge of making this determination?
How does the organization distinguish volunteer licensed independent practitioners (LIPs) from
☐ ☐
other LIPs?
Staff Member: Have you ever worked with a privileged volunteer licensed independent
☐ ☐
practitioner during an emergency? If so, how did the experience go?
Staff Member: How was the volunteer’s performance monitored? How did you recognize this
☐ ☐
person’s privileging status?
* The use of disaster volunteers is not a requirement; it is at the discretion of the organization.
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
Describe
the
organization’s
approach
to
life
safety*
as
fire
and
smoke
protection,
including
how
that
approach
ensures
compartmentation.†
☐
☐
If you maintain a Statement of Conditions, how frequently do you review it? ☐ ☐
May
I
see
your
current
life
safety*
floor
plans
(drawings)?
Please
point
out
to
me
the
following:
• A
legend/key
that
clearly
identifies
all
features
of
life
safety
in
the
facility
• Areas
of
the
building
that
are
fully
sprinklered
(if
the
building
is
partially
sprinklered)
• Locations
of
hazardous
storage
areas
• Locations
of
all
fire
rated
barriers§,
smoke
barriers,
and
designated
smoke
compartments†
☐
☐
• Indications
of
the
size
of
the
identified
suites—both
sleeping
and
nonsleeping
• Locations
of
chutes
and
shafts,
such
as
those
in
elevators,
laundry,
and
other
vertical
openings
• Any
approved
equivalencies
or
waivers
[For
organizations
designated
as
health
care
occupancy
under
the
Life
Safety
Code™‡]
What
are
the
fire
ratings
of
the
fire
barriers§
in
this
area
of
the
facility?
In
common
walls
between
or
within
buildings?
In
hazardous
areas?
☐
☐
What are the fire ratings of any vertical opening in your facility, including exit stairs? ☐ ☐
Do
fire
barriers§
extend
from
outside
wall
to
outside
wall,
and
from
floor
to
ceiling
or
roof?
Specifically,
do
the
fire
barriers
extend
from
the
floor
slab
to
the
floor
or
roof
slab
above
and
from
the
outside
edge
of
the
building
to
the
opposing
outside
edge?
Can
you
please
show
me
examples
☐
☐
of
this?
What are the latching and closing abilities of fire barrier§ doors in this area? ☐ ☐
What is the fire rating for fire barrier§ door assemblies in this area? ☐ ☐
What
gap
is
allowed
between
fire
barrier§
door
pairs?
What
gap
is
allowed
between
the
bottom
edge
of
the
doors
and
the
floor?
☐
☐
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 3
Please describe the purpose, size, and material of protective plates used on fire barrier§ doors. ☐ ☐
How
do
the
fire
barrier§
doors
to
the
trash
and
laundry
chutes
and
the
doors
to
the
chute
discharge
within
the
chute
discharge
room
work?
What
are
the
fire
ratings
of
the
trash
and
☐
☐
laundry
chute
walls
and
the
chute
discharge
door
within
the
chute
discharge
room?
Are
there
at
least
two
smoke
compartments†
for
every
story
in
your
facility
that
includes
patient
sleeping
or
treatment
rooms?
☐
☐
Please
describe
the
doors
in
smoke
barriers§
in
this
area,
including
ability
to
close,
spacing,
material,
and
protective
plates.
☐
☐
Do
you
limit
access
to
barriers§
to
avoid
inadvertent
breaches,
such
as
holes
(“penetrations”)?
Have
you
had
any
recent
barrier
breaches—accidental
or
purposeful?
If
so,
how
was
the
barrier
☐
☐
repaired?
What
is
the
fire
rating
of
dampers
used
in
ducts
that
penetrate
your
fire
rated
and
smoke
barrier§
walls
and
through
floors?
☐
☐
What
fire-‐rated
materials
does
your
organization
use
to
seal
openings
and
joints
in
walls
and
floors?
Has
that
material
been
approved
by
a
designated
testing
agency?
☐
☐
Do
you
ever
prop
doors
open
or
disable
the
latching
mechanisms
on
doors?
If
so,
under
what
conditions?
☐
☐
How
often
do
you
test
your
fire
barrier§
doors?
Where
is
documentation
of
that
testing
kept?
Who
monitors
the
testing
results?
How
are
they
reported
and
to
whom?
How
do
you
document
☐
☐
corrective
action?
Please describe the fire and smoke protection features of your elevators. ☐ ☐
Please describe the fire and smoke protection features of your chute discharge rooms. ☐ ☐
Please tell me about your fire alarm system. How does it work with the fire extinguishing system? ☐ ☐
Where is the master fire alarm panel located? What protections for this panel are in place? ☐ ☐
Where
are
the
sprinklers
located
in
this
area?
What
would
you
do
when
a
sprinkler
is
damaged
or
soiled?
☐
☐
Is
all
sprinkler
system
piping
safe,
secure,
and
free
of
damage?
How
often
are
sprinkler
systems—
including
piping
and
heads—examined,
maintained,
and
tested?
Can
you
please
show
me
where
☐
☐
spare
sprinkler
heads
are
kept?
Are the water-‐flow and valve tamper devices in this area linked to the master fire alarm panel? ☐ ☐
© 2017 The Joint Commission. May be adapted for internal use. Page 2 of 3
Please
describe
the
sprinkler
system,
including
sprinkler
locations,
within
your
trash
and
laundry
chutes.
☐
☐
Are doors kept free from decorations, coverings, and other objects? ☐ ☐
Have
you
implemented
any
interim
life
safety*
measures
(ILSMs)
recently?
If
so,
for
what
reasons
and
what
types
of
ILSMs
are
you
using?
☐
☐
*
Fire
safety
and
life
safety
are
both
terms
that
relate
to
fire
protection,
but
differ
for
the
purposes
of
Joint
Commission
requirements:
Fire
safety
requirements
are
in
the
“Environment
of
Care”
chapter
and
refer
to
fire
protection—and
fire
response—that
is
dependent
on
human
intervention
(fire
drills
and
fire
safety
equipment,
maintaining
means
of
egress
and
fire
exits).
Life
safety
requirements
are
in
the
“Life
Safety”
chapter
and
refer
to
refer
to
fire
protection
dependent
on
building
features
(alarm
and
sprinkler
systems,
construction,
building
design,
hardware).
The
standards
in
the
“Life
Safety”
chapter
are
based
on
the
2012
edition
of
the
Life
Safety
Code,‡
issued
by
the
National
Fire
Protection
Association.
†
Using
barriers,
doors,
and
corridors
to
create
compartments
that
can
contain
fire
and/or
smoke
is
known
as
compartmentation,
or
smoke
compartmentation.
It’s
one
of
the
most
important
features
in
the
Life
Safety
Code
because
it
allows
staff
to
do
a
horizontal
evacuation
to
an
adjacent
compartment
that’s
protected.
Horizontal
evacuation
is
often
enough
to
ensure
safety,
and
can
prevent
the
need
for
you
to
evacuate
your
entire
facility.
‡
Life
Safety
Code®
is
a
registered
trademark
of
the
National
Fire
Protection
Association,
Quincy,
MA.
§
Barriers
are
separations
for
fire
and
smoke
protection
typically
consisting
of
walls
and
the
features
within
walls
(doors,
windows),
but
not
all
walls
are
barriers.
Smoke
barriers
contain
smoke
and
restrict
its
movement.
Fire
barriers
protect
occupants
from
fire
itself
and
the
products
of
combustion.
Fire
barriers
have
a
fire
rating
based
on
the
length
of
time
they’re
effective
in
fire
containment.
Fire
barrier
doors
occur
in
fire
barriers
and
are
also
fire-‐rated;
they
must
also
have
self-‐closures
or
automatic-‐closing
devices,
and
those
are
required
to
latch.
Smoke
barrier
doors
occur
in
smoke
barriers;
they
must
have
self-‐closures
or
automatic-‐closing
devices
but
ARE
NOT
required
to
latch—IF
the
wall
in
question
is
just
a
smoke
barrier.
If
the
wall
serves
more
than
one
purpose—smoke
and
fire
barrier,
it
DOES
have
to
latch.
© 2017 The Joint Commission. May be adapted for internal use. Page 3 of 3
Are
any
doors
in
a
means
of
egress
locked
on
a
regular
basis?
If
so,
please
describe
how
they
are
☐
☐
able
to
be
unlocked
to
maintain
means
of
egress
when
needed.
Do
fire
barrier*
doors
swing
in
the
correct
direction
in
this
area?
What
about
smoke
barrier
☐
☐
doors?
Are exit stairs continuous from the highest level they serve to the outside of the building? ☐ ☐
How does the organization ensure proper signage in exit stairs? ☐ ☐
How does your organization keep its corridors free from clutter that impedes egress? ☐ ☐
What would you do about items stored in a corridor? Are any items allowed in a corridor? ☐ ☐
What types of carts can be stored in exit corridors? Can anything be stored in an exit enclosure? ☐ ☐
Are
paths
of
egress
adequately
lit?
What
type
of
exit
signage
is
present?
Are
all
signs
placed
☐
☐
appropriately?
Please describe how your organization maintains egress for patients in sleeping suites. ☐ ☐
How
does
the
organization
maintain
the
exit
through
the
passageway
to
a
public
way?
☐
☐
*
Barriers
are
separations
for
fire
and
smoke
protection
typically
consisting
of
walls
and
the
features
within
walls
(doors,
windows),
but
not
all
walls
are
barriers.
Smoke
barriers
contain
smoke
and
restrict
its
movement.
Fire
barriers
protect
occupants
from
fire
itself
and
the
products
of
combustion.
Fire
barriers
have
a
fire
rating
based
on
the
length
of
time
they
are
effective
in
fire
containment.
Fire
barrier
doors
occur
in
fire
barriers
and
are
also
fire-‐rated;
they
must
also
have
self-‐closures
or
automatic-‐closing
devices,
and
those
are
required
to
latch.
Smoke
barrier
doors
occur
in
smoke
barriers;
they
must
have
self-‐closures
or
automatic-‐closing
devices
but
ARE
NOT
required
to
latch—IF
the
wall
in
question
is
just
a
smoke
barrier.
If
the
wall
serves
more
than
one
purpose—smoke
and
fire
barrier,
it
DOES
have
to
latch.
© 2017 The Joint Commission. May be adapted for internal use. Page 1 of 1
KEY FEATURES
KEY AUDIENCES
Accreditation professionals
Performance improvement specialists
Department heads
Risk managers
Medication safety officers and patient safety officers
Bar Code